Inclusion, characteristics and outcomes of people requiring palliative care in studies of non-pharmacological interventions for delirium : A systematic review by Hosie, Annmarie et al.
This is a repository copy of Inclusion, characteristics and outcomes of people requiring 
palliative care in studies of non-pharmacological interventions for delirium : A systematic 
review.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/148851/
Version: Accepted Version
Article:
Hosie, Annmarie, Siddiqi, Najma orcid.org/0000-0003-1794-2152, Featherstone, Imogen 
orcid.org/0000-0002-9042-7600 et al. (8 more authors) (2019) Inclusion, characteristics 
and outcomes of people requiring palliative care in studies of non-pharmacological 
interventions for delirium : A systematic review. Palliative Medicine. 269216319853487. pp.
878-899. ISSN 0269-2163 
https://doi.org/10.1177/0269216319853487
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless 
indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by 
national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of 
the full text version. This is indicated by the licence information on the White Rose Research Online record 
for the item. 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
For Peer Review
Inclusion, characteristics and outcomes of people requiring 
palliative care in studies of non-pharmacological 
interventions for delirium: a systematic review
Journal: Palliative Medicine
Manuscript ID PMJ-18-0287.R2
Manuscript Type: Review Article
Date Submitted by the 
Author:
12-Apr-2019
Complete List of Authors: Hosie, Annmarie; University of Technology Sydney, IMPACCT (Improving 
Palliative, Aged and Chronic Care through Clinical Research and 
Translation)
Siddiqi, Najma; University of York
Featherstone, Imogen; University of York
Johnson, Miriam; University of Hull, Wolfson Palliative Care Research 
Centre
Lawlor, Peter; University of Ottawa, Palliative Care; Bruyere Continuing 
Care, Palliative Care
Bush, Shirley; 3. University of Hull
Amgarth-Duff, Ingrid; University of Technology Sydney, IMPACCT 
(Improving Palliative, Aged and Chronic Care through Clinical Research 
and Translation)
Edwards, Layla; University of Technology Sydney, IMPACCT (Improving 
Palliative, Aged and Chronic Care through Clinical Research and 
Translation)
Cheah, Seong Leang; University of Technology Sydney, IMPACCT 
(Improving Palliative, Aged and Chronic Care through Clinical Research 
and Translation)
Phillips, Jane; University of Technology, Sydney, IMPACCT (Improving 
Palliative, Aged and Chronic Care through Clinical Research and 
Translation)
Agar, Meera; University of Technology Sydney, IMPACCT (Improving 
Palliative, Aged and Chronic Care through Clinical Research and 
Translation)
Keywords: clinical trial, delirium, hospice, inpatient, palliative care, review
Abstract:
Background 
Delirium is common, distressing, serious and under-researched in 
specialist palliative care settings. 
Objectives 
To examine whether people requiring palliative care were included in 
non-pharmacological delirium intervention studies in inpatient settings, 
how they were characterised, and what their outcomes were. 
Design 
Systematic review (PROSPERO 2017 CRD42017062178). 
Data sources 
http://mc.http://mc.manuscriptcentral.com/palliative-medicine
Palliative Medicine
For Peer Review
Systematic search in March 2017 for non-pharmacological delirium 
intervention studies in adult inpatients. Database search terms were 
delirium, hospitalisation, inpatient, palliative care, hospice, critical 
care, geriatrics. Scottish Intercollegiate Guidelines Network 
methodological checklists guided risk of bias assessment. 
Results 
The 29 included studies were conducted between 1994-2015 in diverse 
settings in 15 countries (9136 participants, mean age 76.5 years [SD 
8.1], 56% women). Most studies tested multicomponent interventions 
(n=26) to prevent delirium (n=19). Three-quarters of the 29 included 
studies (n=22) excluded various groups of people requiring palliative 
care; however, inclusion criteria, participant diagnoses, illness severity 
and mortality indicated their presence in almost all studies (n=26). Of 
these, 21 studies did not characterise participants requiring palliative 
care or report their specific outcomes (72%), four reported outcomes for 
older people with frailty, dementia, cancer and comorbidities, and one 
was explicitly focused on people receiving palliative care. Study 
heterogeneity and limitations precluded definitive determination of 
intervention effectiveness and only allowed interpretations of feasibility 
for people requiring palliative care. Acceptability outcomes (intervention 
adverse events and patients subjective experience) were rarely reported 
overall. 
Conclusion   
Non-pharmacological delirium interventions have frequently excluded 
and under-characterised people requiring palliative care and infrequently 
reported their outcomes. 
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Inclusion, characteristics and outcomes of people 
requiring palliative care in studies of non-pharmacological 
interventions for delirium: a systematic review
Abstract
Background 
Delirium is common, distressing, serious and under-researched in specialist palliative care 
settings.
Objectives
To examine whether people requiring palliative care were included in non-pharmacological 
delirium intervention studies in inpatient settings, how they were characterised, and what 
their outcomes were.
Design 
Systematic review (PROSPERO 2017 CRD42017062178).
Data sources
Systematic search in March 2017 for non-pharmacological delirium intervention studies in 
adult inpatients. Database search terms were delirium, hospitalisation, inpatient, 
palliative care, hospice, critical care, geriatrics. Scottish Intercollegiate Guidelines 
Network methodological checklists guided risk of bias assessment.
Results 
The 29 included studies were conducted between 1994-2015 in diverse settings in 15 
countries (9136 participants, mean age 76.5 years [SD 8.1], 56% women). Most studies 
tested multicomponent interventions (n=26) to prevent delirium (n=19). Three-quarters of 
the 29 included studies (n=22) excluded various groups of people requiring palliative care; 
however, inclusion criteria, participant diagnoses, illness severity and mortality indicated 
their presence in almost all studies (n=26). Of these, 21 studies did not characterise 
Page 3 of 91
http://mc.http://mc.manuscriptcentral.com/palliative-medicine
Palliative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
2
participants requiring palliative care or report their specific outcomes (72%), four reported 
outcomes for older people with frailty, dementia, cancer and comorbidities, and one was 
explicitly focused on people receiving palliative care. Study heterogeneity and limitations 
precluded definitive determination of intervention effectiveness and only allowed 
interpretations of feasibility for people requiring palliative care. Acceptability outcomes 
(intervention adverse events and patients subjective experience) were rarely reported 
overall. 
Conclusion  
Non-pharmacological delirium interventions have frequently excluded and under-
characterised people requiring palliative care and infrequently reported their outcomes. 
Key words
Clinical trial, Delirium, Hospice, Inpatient, Palliative Care, Review
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Key statements
What is already known about the topic?
 Delirium is a distressing and serious neurocognitive condition that frequently occurs for 
patients in palliative care inpatient settings.
 In contrast to other hospital settings, there is limited evidence to guide non-
pharmacological intervention to prevent and treat delirium in palliative care inpatient 
settings.
What this paper adds
 This review found that various groups of people requiring palliative care were excluded 
from three-quarters of non-pharmacological delirium intervention studies in inpatient 
settings; despite this, they were present in most studies and their outcomes were 
reported in five. 
 Non-pharmacological delirium interventions appear feasible for people requiring 
palliative care yet there is no definitive evidence they are effective or acceptable for this 
inpatient group.
Implications for research
 Phase II and III randomised controlled trials of non-pharmacological interventions to 
prevent and treat delirium are needed in specialist palliative care settings.
 Adaptations to future trials of non-pharmacological delirium interventions in other 
inpatient settings are needed to promote representative study populations and allow 
outcomes for sub-groups of people requiring palliative care to be reported. 
 Additional outcomes related to patient and family subjective experience, goals of care 
and quality of life would enhance the relevance of delirium intervention research in 
inpatient settings where people are cared for at the end of life.  
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Introduction
Delirium is a serious complication of medical illness and hospitalisation.1 The condition is 
characterised by acute disturbances to attention, awareness and cognition, has 
multifactorial aetiology, and variously affects memory, language and visuospatial ability, 
orientation and perception.2 Affected persons often experience feelings of fear, humiliation, 
confusion and disconnection from others.3, 4 Family members experience distress when 
delirium causes sudden changes in behaviour and decline in the person they love.5 6  
Patients who experience an episode of delirium during hospitalisation experience many 
poorer outcomes, including being more likely to die.1, 7, 8 
Delirium most often occurs in people with older age, advanced or severe illness and/or pre-
existing cognitive impairment. Hospital-wide, one in five patients have delirium,9 with 
occurrence higher again in intensive, geriatric and palliative care units.1, 6 Studies of delirium 
epidemiology in palliative care inpatient units that screened patients at least daily reported 
incidence of 33 45% and prevalence of 58-88% in those who died. 
Development of delirium guidelines1, 10-13 policy14 and international advocacy15 indicate 
growing awareness of the seriousness and prevalence of delirium and importance of 
evidence based care for hospitalised patients.16, 17 There now is sufficient evidence to 
implement non-pharmacological interventions for delirium in certain hospital settings.18, 19 
For example, reviews of studies of multicomponent interventions addressing physical and 
cognitive activity, sleep, hearing, vision and hydration, as in the original Hospital Elder Life 
Program (HELP) study,20 reported reduction in incident delirium in older hospitalised 
patients.21-23 Reduction in length of hospital stay and improvement in return to independent 
living were also demonstrated.22  
In contrast, guideline recommendations for non-pharmacological interventions as the first 
approach to prevent and treat delirium during advanced illness and at the end of life are not 
evidence based.10, 17, 24 A recent scoping review reported the need to generate evidence to 
inform clinical care in palliative care settings and populations, for non-pharmacological 
interventions in particular.25 Poorer outcomes with antipsychotics,26 and over-sedation 
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when benzodiazepines were given for agitated delirium,27 in two recent trials in specialist 
palliative care settings also highlight the need to establish drug-free ways to prevent and 
relieve the difficulties of delirium at the end of life. 
In response, the authors established the Studies to Understand and Improve Delirium Care 
in Palliative Settings international collaborative (SUNRISE) to generate high-quality delirium 
research in palliative care. We identified the need to inform our future trials in palliative 
care through a review of studies of non-pharmacological interventions for delirium 
conducted in a wide range of inpatient settings. This wide review was premised on our 
clinical experience and knowledge that many hospitalised patients have advanced and/or 
serious illness, frailty and high comorbidity and consequently much in common with 
patients in specialist palliative care settings, especially those in intensive care, medical and 
geriatric units where rates of delirium are similarly high. 28, 29 Based on this premise, our 
specific objectives were to examine whether people requiring palliative care were included 
in non-pharmacological delirium intervention studies in various inpatient settings, how 
these participants were characterised, and whether the non-pharmacological interventions 
were effective, feasible and/or acceptable for them. 
Methods
Design
Systematic review of the literature, following the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA).30
Participants/settings 
Adults F%* years) receiving inpatient hospital or hospice care. In this review, we refer to 
hospice as an inpatient facility with the primary function to provide specialist palliative 
care to people with life-threatening illness, and analogous to a palliative care inpatient unit. 
Search strategy
In March 2017, we searched MEDLINE, Embase, CINAHL, PsycINFO, Cochrane Library and 
Web of Science with the following search terms in MEDLINE: Delirium AND Hospitalization 
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OR Inpatient OR Hospice AND Palliative Care OR Critical Care OR Geriatrics. Filters in 
Medline were: 1. Study types: clinical study, clinical trial all, comparative study, controlled 
clinical trial, meta-analysis, multicenter study, pragmatic clinical trial, randomised controlled 
trial, systematic review; 2. Peer reviewed journal and 3. Published from 1980 onward (when 
delirium was first included in the American Psychological Association (APA) Diagnostic and 
Statistical Manual (DSM-III).31 We tailored search terms and filters to subsequent databases. 
We examined reference lists of relevant systematic reviews and meta-analyses identified in 
the search for additional eligible studies.
Inclusion/exclusion criteria
Studies included were primary reports of prospective trials (i.e. studies of an intervention 
with a comparator); with a primary objective to prevent or treat delirium through non-
pharmacological intervention/s in adult patients in hospital or hospice unit settings; a 
primary outcome of delirium incidence, severity or duration; published in English in a peer-
reviewed journal. 
Studies excluded were reports of interventions for alcohol withdrawal delirium only; 
systematic reviews and meta-analyses of non-pharmacological delirium intervention/s; 
studies where the primary outcome was not participants delirium status (e.g. process or 
cost effectiveness outcomes, validation of delirium tools); studies that did not use diagnostic 
criteria or a tool with established psychometric properties to measure delirium; protocols; 
and ongoing studies. 
Study selection, data extraction and management  
We imported search results into Endnote X7 software, removed duplicates and exported 
results to Covidence,32 where three reviewers [IAD, LE, AH] independently applied eligibility 
criteria to titles and abstracts. Reviewers compared decisions about inclusion, documented 
reasons for exclusions at full text review and resolved discrepancies through discussion. Two 
reviewers [IAD, LE] extracted data according to the template for intervention description 
and replication (TIDieR) checklist and guide 33 into an Excel V15.28 spreadsheet. The lead 
reviewer [AH] contributed guidance, oversight and independent data checking. 
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Risk of bias assessment 
Two reviewers [LE and AH] independently assessed each study for selection, performance, 
detection, attrition, confounding, and reporting biases according to the Scottish 
Intercollegiate Guidelines Network (SIGN) Methodology Checklists34 for controlled trials and 
cohort studies. Discrepancies were resolved through discussion.  
Outcomes
To identify our sample of interest (i.e. people requiring palliative care), we examined study 
inclusion and exclusion criteria, participant diagnoses (including severity or staging), and 
mortality. We assessed eligibility criteria and diagnoses against the Gold Standards 
Framework Proactive Identification Guidance (GSF PIG), a clinical tool to help identify 
people likely to need additional supportive (i.e. palliative) care in the last 12 months of life.29 
According to the GSF PIG, these people are those with life-threatening conditions, including 
illnesses that are advanced, progressive, incurable and/or likely to cause acute crises; frailty 
and co-morbidities; and sudden catastrophic events.
Previous reviews have reported effectiveness outcomes of non-pharmacological delirium 
interventions for the entire study sample; 21-23 whereas this review focused on effectiveness, 
feasibility and acceptability outcomes of our sample of interest. We examined effectiveness 
according to each studys primary outcome and any sub-group analysis for our sample of 
interest. We assessed feasibility by examining intervention characteristics, adherence and 
study modifications, and acceptability through intervention-related adverse effects and 
patient, family, clinician and volunteer subjective experiences of the interventions.
Synthesis and analysis plan
We generated tables, text and graphs to report study characteristics, participants, 
interventions and outcomes. Data transformation and descriptive numerical analyses were 
performed using Excel. We planned to perform subgroup meta-analysis using Review 
Manager Analyses software 35 of intervention effectiveness if we could definitively 
distinguish our sample of interest and if interventions and comparators and measures were 
comparable.
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Updated search
We updated the search prior to publication in February 2019 and identified two new eligible 
papers published after the original search date.36, 37 There were not incorporated as neither 
paper altered the conclusions of the review. 
Results
The original database search strategy generated 4300 records. After removing 35 duplicates 
and 4169 records through title and abstract screening, we reviewed 69 full text papers and 
excluded 48. We included another eight through reference list searching, resulting in 29 
papers reporting 29 studies for inclusion (Figure 1).
(Insert Figure 1 PRISMA Flow Diagram here)30
Study characteristics
The 29 studies were conducted between 1994-2015 across 15 countries: six in the US,38 39 40 
41 42 20 three each in Australia,43 44 45 Belgium,46-48 and Canada,49-51 two each in the 
Netherlands52, 53 and Sweden,54, 55 and one each in Chile,56 France,57 Ireland,58 Italy,59 
Japan,60 Korea,61 Singapore,62 Spain,63 UK,64 and the US/Canada65  (Table 1). 
Study designs were before/after studies (one with an additional concurrent arm62) (n=11),38-
41, 44, 45, 48, 52, 57, 62, 64 randomised controlled trials (RCTs) (n=10),42, 43, 47, 50, 51, 53, 55, 56, 61, 65 non-
randomised controlled trials (one with matched participants20) (n=5),20, 46, 54, 59, 63 a quasi-
experimental study,49 a pilot randomised controlled trial,60 and a comparative time series 
study.58 
Services and settings were medical (n=10),20, 41, 43, 50-52, 54, 56, 59, 63 geriatric (n=7),39, 44, 55, 57, 59, 
62, 63 medical and/or surgical intensive care (n=6),38, 40, 47, 58, 61, 64 perioperative hip fracture 
(n=6),42, 45, 46, 48, 55, 65 other perioperative (n=3) 52, 53, 60 and palliative care and hospice units 
(n=1), 49 with eight studies involving more than one service.47, 52, 55, 58, 59, 61, 63, 64
Most studies tested multicomponent interventions (n=26) and aimed to prevent delirium in 
non-delirious participants (n=19) (Table1). Six studies aimed to prevent and treat delirium 38, 
42, 48, 54, 55, 65 three were treatment only studies.50, 51, 62 
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(Insert Table 1 Study characteristics here) 
Code: P Prevention, T Treatment, RCT Randomised controlled trial, CTS Comparative time series, B/A Before
after study, CT Controlled trial, ICU Intensive Care Unit, NR Not reported, MC Medical Centre, M 
Multicomponent, PRCT Pilot RCT, QE Quasi-experimental, S Single component 
 Numbers signify the domains in which the study was assessed as having low risk of bias: 1 = Representative 
study sample; 2 = Concealed allocation; 3 = Random sequence generation; 4 = Blinded participants and 
intervention personnel; 5 = Blinded outcome assessors; 6 = Valid, reliable delirium measures; 7 = <20% sample 
lost to analysis; 8 = Intention to treat analysis; 9 = Confounders accounted for; 10 = Only a priori outcomes 
reported
Risk of bias assessment
Almost all studies were assessed as having at least one form of selection bias (n=28). The 
exception was a Chilean RCT of a prevention intervention where family members delivered 
cognition, vision, and hearing strategies to patients.56 Eight RCTs minimised internal 
selection bias through concealed allocation and random sequence generation.42, 43, 47, 50, 53, 55, 
56, 65 There was high risk of performance bias in all studies, due to the inherent difficulty of 
blinding non-pharmacological interventions: one RCT blinded participants to their allocation, 
43 and no studies blinded those performing the intervention. Detection bias was minimised 
in eight studies through blinded outcome assessors combined with valid, reliable delirium 
measures.42, 43, 47, 50, 51, 53-55 Although we excluded studies that did not use delirium 
diagnostic criteria and/or a tool with established psychometric properties, three studies 
were assigned uncertain risk of detection bias due to retrospective assignment of delirium 
status when the Confusion Assessment Method (CAM) was not performed during weekends 
in two before-after studies;41, 45 and when delirium incidence was reported as a mean rather 
than a proportion in a comparative time series study.58 High risk of detection bias was 
assigned to a delirium prevention study in seven Canadian palliative care units due use of a 
screening tool, the Confusion Rating Scale (CRS) to measure delirium incidence, severity and 
duration.49 Six studies had low risk of attrition bias.42, 43, 50, 55, 56, 63 Confounders were 
accounted for in 17 studies.20, 39, 40, 42, 46, 47, 49-52, 54, 55, 58, 59, 61, 63, 65 Most studies (n=22) 
reported only a priori outcomes,20, 38-43, 46, 48, 50-53, 55-57, 60-65 which we assessed by information 
provided within the papers rather than through examination of trial registrations or 
published protocols, which no studies cited.
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Figure 2 presents overall risk of bias in the included studies.
(Insert Figure 2 Overall risk of bias graph here)
Figure 2: Overall risk of bias
Participant characteristics
There were 9136 participants (n=4553 in intervention arms) across the 29 studies (Table 2). 
Sample sizes ranged from 15-1516 participants. Participants overall mean age (excluding 
two studies that reported only age range or median) 48, 58 was 76.5 years (SD + 8.1). There 
were more female participants (56%) than male. 
Inclusion and exclusion criteria 
Inclusion
Most studies (n=19) included only patients aged 65 years and older (Table 2). Twenty-two 
studies included consecutively admitted patients, 16 of which further required certain 
physical conditions to be present (e.g. frailty,53 hip fracture,42, 45, 46, 48, 55, 65 anemia,65 
dementia,57 advanced cancer,49 oesophageal cancer surgery60). Five studies included only 
patients with risk factors for delirium20, 44, 52, 56, 63 and three included only patients with 
delirium.50, 51, 62 The study in seven Canadian palliative care units (hereafter termed the 
palliative care unit study) included only patients with terminal cancer, defined as dying 
within 90 days of admission which was retrospectively identified. This study had the largest 
sample of all the studies (n=1516, 17%).49 
Exclusion
Twenty-three studies excluded patients on various diagnostic grounds (Table 2). These were 
stroke or cerebrovascular accident (CVA), moderate-severe traumatic brain injury or coma 
(n=9);20, 38, 43, 48, 50, 51, 59, 62, 63 dementia or prior cognitive impairment (n=7);20, 38, 44, 47, 61, 63, 64 
psychiatric disorders or alcohol/drug addiction (n=6);43, 44, 59-61, 64 pathological fracture 
(n=4);46, 48, 55, 65 poly- or multiple trauma (n=2);46, 48 neurologic diagnosis/neurosurgical 
(n=2);61, 64 metastatic cancer or referred to oncology services (n=2);42, 50 and others 
(myocardial infarction,65 severe renal failure,55 brain concussion,48 history of sleep 
pathology,64 severe rheumatoid arthritis 55 and severe hip osteoarthritis55). 
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Fifteen studies excluded patients with impaired verbal communication or who were 
otherwise unable to complete study assessments.20, 38, 39, 41, 43, 46, 48, 50, 52, 53, 59, 61-63, 65 Six 
studies excluded patients with hearing and/or visual impairment.46-48, 60, 61, 64 Three studies 
excluded patients isolated for infection.43, 61, 62
Eight studies explicitly excluded patients expected to die, using the following terms: 
terminal diagnosis or terminal illness (n=3),20, 58, 62 terminal condition and receiving 
comfort care (on the basis that they were unlikely to benefit from the intervention) 
(n=2),41, 44 life expectancy less than six months,46 metastatic cancer or comorbid illnesses 
likely to reduce life expectancy to less than six months,42 death expected within 24 
hours,43 and dangerously ill.62  
Two studies excluded participants who subsequently died from analysis;51, 52 a delirium 
prevention study in elderly care wards excluded 70% of 2162 admitted patients due to being 
too unwell; 39 and another study excluded patients with deterioration of condition.60 
The palliative care unit study excluded patients who lived for more than 90 days or who 
were still alive at discharge from analysis.49
Characterisation of study participants  
Participant diagnoses and illness severity
Reporting of participant diagnoses, illness severity and mortality varied. Fifteen studies 
reported co-morbid diagnoses, twelve reported only primary diagnoses, and four reported 
both (Table 2). Diagnoses categorisation varied. Studies rarely reported staging of 
diagnoses (n=2).49, 56 
Sixteen studies reported illness severity for all participants using at least one measure, more 
often as a mean or median score (n=15)20, 38, 43, 46, 47, 50, 52, 55, 56, 59, 61-65 than by categorising 
participants proportionally (n=6).20, 39, 42, 47, 52, 62 The most frequently used illness severity 
measures were the Charlson Comorbidity Index (CCI)66 (n=7; reported as: mean scores 2.3 - 
3.3,46, 50, 62 median 2,43, 56 and scores of four or greater 19.8%39 and 39%42); and the Acute 
Physiology And Chronic Health Evaluation II (APACHE II) 67 (n=6; mean scores 11.3-15.6).20, 43, 
59, 61, 63, 64 Two ICU studies that measured illness severity using the APACHE II reported 
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means scores (13.9-14.6) 61, 64 approximately equivalent to or less than those reported in 
three of four medical and geriatric unit studies (14.1-15.6).20, 43, 59 Other measures were the 
Cumulative Illness Rating ScaleGeriatrics (CIRS-G) comorbidity and severity indexes;52, 59, 68 
American Society of Anesthesiologists physical status classification (ASA)52, 65, 69; Blessed 
Dementia Rating Scale;20, 42, 70 Modified Early Warning Score (MEWS);39, 71 Sepsis-related 
Organ Failure (SOFA);47, 72 Risk, Injury, Failure, Loss of kidney function, and End-stage kidney 
disease (RIFLE);47, 73 Simplified Acute Physiology Score (SAPS 3);47, 74 and the 15-item 
Geriatric Depression Scale (GDS-15).55, 75 
Three studies reporting comorbidities without the CCI reported: i. 60% had more than two 
comorbidities (diabetes, COPD, hypertension, myocardial infarction, other cardiovascular 
disorders, neurological disorders, cerebrovascular disorders, hearing and vision problems, 
memory problems in daily life, psychiatric disorders or musculoskeletal disorders);53 ii. 72% 
had at least one co-morbid illness;47 and iii. a mean of 2.7 comorbidities.63 
Almost every diagnosis, sensory deficit and impairment that were exclusion criteria in some 
studies were reported in the overall study population (Table 2). For example, more studies 
reported participants with dementia or cognitive impairment (n=13) 39, 41-43, 46, 48-51, 55-57, 65 
than excluded people with these conditions (n=7).20, 38, 44, 47, 61, 63, 64
Participant mortality
Mortality was reported in 19 studies at nine different time points, ranging from in the 
ICU38, 40 to one year post intervention. 46, 55, 62  In these studies, 2090 participants died 
(23%). Mortality rates ranged from 1% in three studies20, 47, 61 to 100% in the palliative care 
unit study.49  There were 596 participant deaths in 18 studies reporting mortality that were 
conducted outside of a specialist palliative care setting (12%). High mortality was reported 
for intervention and control medical unit participants at eight weeks (22.1% vs 19.37%; 50 
33% vs 37% for delirious patients51) and at six months (33.8% vs 30.9%);39 and at one year 
for older (F)6+ traumatic hip fracture patients (33% vs 22%).46 Six of the 19 studies 
measuring mortality excluded patients expected to die; despite this exclusion criteria, 134 
participants of these six studies subsequently died during the study period (12%).20, 44, 46, 52, 
58, 62 Fifteen studies reported 21 comparative mortality rates,20, 38-40, 45, 46, 50-55, 61-63 only two 
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of which reported significantly less mortality in intervention cohorts compared to 
controls,54, 61 with one (at day 7 in hospital) not sustained at 30 days in hospital.61 
Study approaches to people requiring palliative care
By examination of these data we identified only one study that explicitly reported outcomes 
for participants requiring palliative care (n=1).49 Using the GSF PIG, we identified another 
four studies that reported primary or sub-group effectiveness outcomes for older people 
likely to require palliative care due to the presence of frailty, dementia, cancer and 
comorbidity.42, 52, 53, 57  All five studies were of interventions to prevent delirium. Twenty-
two studies either explicitly or resultantly excluded groups of people requiring palliative 
care (76%). 20, 38, 39, 41-44, 46-48, 50-52, 55, 58-65 Yet, through our interpretation of reported 
diagnoses, levels of comorbidity, frailty and mortality (signified with a  in Table 2), we also 
identified that people requiring palliative care were present in 21 studies that did not 
specifically characterise them or report their outcomes (72%). 20, 38-41, 43, 45-48, 50, 51, 54-56, 58, 61-
63, 65 Figure 3 presents these findings diagrammatically. 
(Insert Table 2: Study inclusion and exclusion criteria and participant diagnoses, illness 
severity and mortality)
* Statistically significant difference  Intervention and control participants combined   Rounded to nearest 
whole number  Interpreted as indicating need for palliative care 
Illness severity measures: Higher scores represent higher illness severity. AIS Abbreviated Injury Scale, 
APACHE II Acute Physiology and Chronic Health Evaluation (scores 0-71), ASA American Society of 
Anesthesiologists physical status classification (I: normal healthy patient  - VI: a declared brain-dead patient 
whose organs are being removed for donor purposes), BDRS Blessed Dementia Rating (scores 0-28, cut-off for 
impairment > 4), CCI Charlson Comorbidity Index (scores 0-37), CIRS-G Cumulative Illness Rating Scale
Geriatrics (scores 0-56), CSI Clinical severity of illness (1 (mild) - 9 (moribund)), GCS Glasgow Coma Scale 
(scores 3-15; scores 3-8 = coma), GDS-15 15-item Geriatric Depression Scale F) = suggests depression and 
need for assessment, F%% = depression/severe depression), ISS Injury Severity Score (scores 1-75), MEWS 
Modified Early Warning Score (score F6 is statistically linked to increased likelihood of death or admission to 
an intensive care unit), RIFLE (Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease 
categories), SAPS 3 Simplified acute physiology score (scores 0-217), SOFA Sepsis-related Organ Failure 
Assessment (scores 0 to 24). Other abbreviations: ADL activities of daily living, AF atrial fibrillation, Ca cancer, 
CAM Confusion Assessment Method, CAM-ICU Confusion Assessment Method for the Intensive Care Unit, CI 
cognitive impairment, CKD Chronic Kidney Disease, COPD chronic obstructive pulmonary disease, CVD 
cardiovascular disease, CVA cerebrovascular accident, DM diabetes mellitus, ED Emergency Department, GI 
gastrointestinal, HF heart failure, hrs hours, HT hypertension, I/C intervention/control, ICU intensive care unit, 
IHD ischaemic heart disease, IQR interquartile range, MI Myocardial Infarction, MMSE Mini-Mental State 
Examination, NR not reported, O/A on admission, OP osteoporosis, PVD peripheral vascular disease, RASS 
Richard Agitation Sedation Scale, RF renal failure, SD standard deviation, SICU surgical intensive care unit, TIA 
transient ischemic attack, UTI urinary tract infection.
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Figure 3: Study approaches to people requiring palliative care
NB: Combined percentages do not add up to 100% as studies simultaneously excluded and reported people requiring 
palliative care.
Effectiveness outcomes for people requiring palliative care 
Overall, 20 studies reported that the intervention was effective according to at least one 
primary outcome (69%)20, 38-42, 44-46, 51, 54-57, 59-64 
The one study explicitly focused on preventing delirium in people receiving palliative care 
(patients with terminal cancer) tested three primarily nurse-delivered intervention 
components for orientation, informing family, and assessment of medication risk factors 
plus querying physicians about changes to medication and found no statistically significant 
difference in delirium incidence (p= 0.66, OR 0.94), severity or duration between 
intervention and control sites.49 
Outcomes of four participant groups that we identified as requiring palliative care were as 
follows: 
A delirium prevention RCT of a geriatric liaison intervention of comprehensive assessment, 
cognitive and physical activity, hearing, vision and nutrition for frail elderly cancer patients 
undergoing surgery for a solid tumour reported no significant difference between delirium 
incidence in intervention and control groups (9.4% vs. 14.3%, OR: 0.63, 95% CI: 0.291.35).53
A delirium prevention RCT of geriatric consultation and multiple care components (Table 3) 
performed analysis for the sub-group pf people with dementia within a perioperative hip 
fracture population, reporting a non-statistically significant reduction in delirium incidence 
in the intervention group compared with control (n=13 (62%) vs. n=20 (69%) p=0.6).42 
A delirium prevention before-after study of orientation and communication strategies for 
patients with dementia in a French acute geriatric unit reported a 66% relative risk 
reduction of delirium in the after cohort (RRR 0.34 IC 95% 0.150.78).57
A delirium prevention before-after study of delirium/cognitive screening, comprehensive 
assessment, cognitive and physical activity, nutrition, falls prevention, medication review 
and staff education in frail elderly surgical patients found no statistically significant 
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difference in incidence of delirium (11% vs 10% p=0.945) or cognitive decline (15% vs 12% 
p=0.431) in the before group compared with the after.52  
Due to heterogeneity of study interventions and measures (Table 2), we did not conduct 
meta-analysis of these effectiveness outcomes. 
Types of outcomes measured in the included studies
Twenty-nine different outcomes were measured overall (Figure 4). There were nine 
different primary outcomes, the most frequent was delirium incidence (n=21). 20, 38, 39, 41-46, 
48, 49, 52, 53, 56-61, 63, 64 Of the 22 different secondary outcomes, the most often reported was 
length of ICU or hospital stay (n=16).38-43, 45, 46, 48, 50, 51, 53-56, 62  
Figure 4: Types and rates of outcomes measured
Feasibility outcomes
Intervention components
The interventions consisted of 24 components overall, varying in type and number per study 
(1-15) (M=6.3 SD +4) (Table 3). The type and number of strategies in each component also 
varied (data not reported here).
Eighteen multicomponent prevention interventions most often included strategies for: 
cognitive activity (n=15);20, 39, 41, 43-45, 49, 52, 53, 56, 57, 59, 61, 63, 64 physical activity (n=9);20, 39, 43, 45, 52, 
53, 59, 63, 64 hearing (n=9);20, 39, 41, 44, 45, 53, 56, 61, 63 vision (n=9);20, 39, 41, 44, 45, 53, 56, 61, 63 sleep-wake 
cycle preservation (n=8);20, 40, 41, 45, 59, 61, 63, 64 nutrition (n=8);41, 44, 45, 52, 53, 59, 61, 63 staff 
education; 39-41, 52, 59, 61, 63, 64 and hydration (n=7). 20, 41, 44, 45, 59, 61, 63 These components largely 
correspond to those of the original HELP study.20 
Components of six delirium prevention and treatment interventions were more diverse 
(M=8), with staff education (n=4),38, 48, 54, 55 staff changes (n=3) 48, 54, 55 and strategies for pain 
(n=3) most often included.42, 48, 55 
The most common components of three delirium treatment interventions were cognitive 
activity (n=3);50, 51, 62 physical activity (n=3);50, 51, 62 hearing (n=3);50, 51, 62 vision (n=3);50, 51, 62 
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sleep-wake cycle preservation (n=2);50, 62 and environmental changes (e.g. adjustments to 
lighting and noise) (n=2).51, 62 
Overall, multicomponent interventions also often included: family involvement (e.g. 
information/education about delirium, increased family presence) (n=9); 38, 45, 49-51, 56, 58, 59, 61 
environmental strategies (n=9); 38, 40, 42, 45, 50, 51, 61, 62, 64 and comprehensive assessment 
(n=8).42, 46, 50-53, 55, 61 Pharmacological strategies (e.g. medication reviews and alerts, 
protocols for pain and sedation strategies) were present in half of the multicomponent 
interventions (n=12).38, 40-42, 45, 48, 49, 52, 55, 59, 61, 64 
The three single component interventions were blood transfusion,65 bright light therapy60 
and earplugs at night.47 
The five studies that reported effectiveness outcomes for our sample of interest addressed: 
cognitive activity,42, 49, 52, 53, 57 physical activity,42, 52, 53 comprehensive assessment,42, 52, 53 
hearing,42, 53 vision,42, 53 nutrition,42, 52, 53 pharmacological strategies,42, 49, 52 environmental 
strategies42, 57 family involvement,49 staff changes,42 pain,42 medical complications,42 
oxygen,42 staff education,52 falls prevention52 delirium/cognitive screening52 and 
bladder/bowel function42 (Figure 5).
Intervention delivery
Specialist geriatric clinicians or teams led almost half of the interventions, as either 
consultants or directly (n=12).20, 39, 42, 45, 46, 50-53, 55, 62, 63 Interventions were delivered by 
interdisciplinary teams (n=5),20, 38, 45, 46, 55 physicians and nurses (n=3),49-51 nurses alone 
(n=3),47, 48, 61, physician, nurse and physiotherapists (n=2),59, 64 family members (n=2),56, 58 
and physiotherapists and allied health assistants (n=1).43 Volunteers delivered part or all of 
the intervention in four studies.20, 41, 44, 52 Three studies did not report who delivered the 
intervention, including two single component interventions. 57, 60, 65 Most studies (n=25) 
wholly or partly tailored components and strategies to patients individual needs (Table 3).
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(Insert Table 3 Intervention characteristics here)
Abbreviations: ICU Intensive Care Unit, NR Not reported, OA On admission, OT Occupational therapist, PT 
physiotherapist Component codes: C Cognitive activity, E Physical activity, H Hearing, V Vision, P Sleep-wake 
cycle preservation, W Hydration, S Staff education, F Family involvement, N Nutrition, Pa Pain, O Oxygen, L 
Falls prevention, G Staff changes, B Bladder/bowel, J Environment/lighting/noise, CA Comprehensive 
assessment, BT Blood transfusion, Z Address medical complications, PE Patient education, Ph Physiological 
monitoring, K Pharmacological
Figure 5: Types and rates of intervention components, including for sample of interest
Code: P Delirium prevention studies, P & T Combined delirium prevention and treatment studies, T Delirium treatment 
studies, S of I Sample of interest 
Adherence
Eighteen studies reported adherence to intervention strategies, using different methods and 
levels of detail (Supplementary Table 1). Almost all reported less than 100% adherence, with 
the exception reporting 100% geriatric nurse compliance with the semi-structured 
protocol.62 The palliative care unit study reported 89.7% overall adherence to the study 
protocol.49 Three studies compared adherence to intervention strategies with that for 
control participants and reported that usual care sometimes mirrored some intervention 
strategies.46, 50, 55 Two studies reported reasons for non-adherence: pharmacological 
sedation, coma and absence of a relative in the palliative care unit study; 49 and patient 
refusal or unavailability, staff member unavailability, and medical contraindications in the 
original HELP study.20
Study modifications
Two studies modified the intervention in the pilot phase, including changes in staff 
education and practice change materials,39 and providing study information to family on 
admission rather than waiting until the researcher was present. 58 The palliative care unit 
study modified the primary outcome measure by not substituting the CRS for the CAM, due 
to CAM completion delays and poor completion rates (39% of participants) caused by the 
challenge of conducting the baseline CAM structured interview in the last days or hours of 
life.49
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Acceptability outcomes
Adverse effects
No study reported systematic processes of attribution of adverse effects to the intervention. 
Ten studies reported adverse events related to hospitalisation rather than the intervention 
38, 44, 51-53, 55, 56, 62, 63 (Figure 4 and Supplementary Table 2). No study reported statistically 
significant increased adverse events for intervention participants. Two simply stated that 
the intervention had no adverse effects.20, 43 A RCT,55 a controlled trial 63 and a before-after 
study 62 reported statistically significant reductions in some adverse events for intervention 
participants: falls,55 physical restraint,62, 63 pressure ulcers,55, 62  infection,55, 62 and sleeping 
problems.55 
Patient, family, clinician and volunteer subjective experiences
No study reported patients subjective experiences of intervention (Supplementary Table 3). 
A survey of family caregivers satisfaction with intervention and care for delirious patients 
within one study found most experienced moderate to high levels of distress (72%), 
believed that the environment and intervention helped the patients recovery (86.6% and 
83.5%, respectively) and that the three most useful strategies were activity, reality 
orientation and thrice-daily mobilisation.62 A before-after study of older medical and 
surgical inpatients interviewed patients, volunteers, nurses and physicians and analysed 
meeting minutes to assess intervention integration in clinical practice, with minimal details 
of analysis methods and findings provided. 52  Four studies reported multidisciplinary and 
expert input during intervention development.39, 40, 45, 61 The RCT of nocte earplugs in the 
ICU stated in the discussion that some participants preferred not to use them in order to 
remain in direct contact with their environment. 47 No studies reported measures of 
patient distress related to delirium (Figure 5).
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Discussion
This review found that studies of non-pharmacological delirium interventions frequently 
excluded and under-characterised people requiring palliative care and subsequently their 
outcomes were infrequently reported. The likely reasons for these findings and how to 
address barriers to inclusion and report characteristics and outcomes for this patient sub-
group in future research are discussed.  
With regards to inclusion, this review identified a selection bias against people requiring 
palliative care through exclusion of people expected to die (using various prognoses and 
terminology) and also of those with greater acuity or severity of illness, particular diagnoses 
and with cognitive, sensory and/or communication impairments. These exclusions were 
rarely explained or justified and often seemingly arbitrary. Nor were they consistent across 
the studies. These exclusions represented people highly at risk of delirium.1, 6 This finding 
reflects those of other reviews that identified selection biases against people with dementia 
in geriatric research76 and older people from clinical trials in oncology.77 Reasons for the 
exclusions identified in our review are likely to be multifactorial. One factor may be 
assumptions that the interventions were not appropriate, possible or likely to be effective 
for people requiring palliative care, as indicated by the two studies which justified the 
exclusion of patients with a terminal condition and requiring comfort care as that the 
intervention would be unlikely to benefit them.41, 44 Historical views that people requiring 
palliative care are separate from the wider hospital population, rather than universally and 
always within it, may also have influenced some exclusion decisions.78, 79 There are also 
pragmatic challenges to ensuring informed consent and completion of study measures when 
patients are frail, expected to decline, and have pre-existing cognitive and sensory 
impairments. However, these challenges may be overcome through a variety of research 
strategies, such as proxy, opt out and advance consent methods, early contact, tailoring of 
interventions and messaging to patients and family, adequate research resources and 
governance, and cluster designs.26, 27, 80, 81 Outcomes such as days alive without delirium or 
coma may promote the inclusion of more severely ill patients in future delirium research, 
because consciousness is pre-requisite for delirium measurement.40, 82  Brief and 
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observational delirium diagnostic tools that can be validly used with patients with cognitive, 
sensory and communication impairment are also available.83-86
Despite most studies excluding certain groups of people likely to require palliative care, 
unsurprisingly we identified that they were indeed present, despite under-reporting of their 
characteristics and outcomes. One reason it was difficult to retrospectively distinguish this 
sub-group for the purposes of ascertaining their outcomes in this review was that the 
studies reported participants diagnoses, illness severity, and mortality using different 
measures, time-points, methods and degrees of detail. While identifying inpatients with 
palliative care needs in hospital is challenging and an uncertain science, both retrospectively 
and prospectively, there are ways it can be achieved. 29, 87-89 In addition to the GSF PIG which 
we applied in this review, 29 the Palliative Care Needs Assessment Tool 90 and the Supportive 
and Palliative Care Indicators Tool (SPICT) 91 can be used to identify which patients are at 
risk of deteriorating and dying in hospital. Other studies suggest identifying patients with 
palliative care needs through the presence of life-threatening illness coupled with receipt 
and acceptance of care focused on supporting quality of life, 87 or retrospectively though the 
use of death registration data. 89 Such methods could be used in delirium intervention 
research in settings where mortality is high, such as intensive care units, where existing 
illness severity measures focus on acuity and intensity of intervention and, despite having 
some prognostic utility, were never designed to identify a patients need for palliative 
care.67, 74, 92
Better characterisation of people requiring palliative care in studies of non-pharmacological 
interventions for delirium would help to build evidence of their outcomes in two ways. 
Firstly, it would allow sub-group analysis to be performed and reported in future studies in 
any setting. This is important because the question of whether delirium can be prevented 
and treated through non-pharmacological means was not definitively determined for this 
population by this review. The multi-site palliative care unit study had the greatest number 
of participants and reported good overall adherence to the study protocol; 49 however, the 
only core care domain 21 was cognitive activity, consisting of nurses orientating patients to 
time, person and place each shift. Planned use of the CAM was not accomplished and the 
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substituted screening tool93 was not a validated tool for delirium diagnosis or severity. All 
participants had terminal cancer and died within 90 days of admission and thereby were 
not fully representative of people requiring inpatient palliative care, including in specialist 
units49, not all of whom will die within three months. Only one geriatric unit study of people 
with dementia reported reduced delirium incidence; however, the report lacked detail, 
including of analysis methods.57 The remaining three studies were focused on frail elderly 
patients with cancer, dementia, hip fracture and comorbidity following surgery,42, 52, 53 a 
level of intervention and delirium risk that many people requiring palliative care would not 
undergo. Lastly, we found no studies focused on non-pharmacological interventions to treat 
delirium in people requiring palliative care, highlighting the particular need to research this 
challenging area of clinical care. 
Secondly, better recognition of people requiring palliative care in delirium research would 
heighten awareness of their needs, which in turn would instigate consideration of outcomes 
that are most meaningful to them. Reducing delirium incidence, duration and severity, 
length of admission and mortality were the foci of the included studies. While worthwhile 
aims at any point in the illness trajectory, more person-centred outcomes, such as reduction 
of delirium related distress, and improved patient and family caregiver experiences of 
decision making, respect and dignity, and quality of life, were almost completely absent. 5, 94 
Measuring these additional outcomes, which are highly valued by patients and family 
caregivers,95, 96 would enrich this field of research and is achievable through both 
quantitative and qualitative methods. Adverse effects of intervention will also be important 
to systematically measure in future trials, given that patients with cognitive impairment 
have increased vulnerability to harm in hospital.97 
Lastly, this review allowed an interpretation that many intervention components are 
feasible for people requiring palliative care by virtue of their delivery to elderly, frail and/or 
critically ill patients with and without delirium in the included studies. However, we suggest 
that studies measuring the feasibility of components of the original HELP intervention 20 that 
were subsequently found to be effective for other older hospitalised patients i.e. those 
targeting cognitive and physical activity, sleep, hearing, vision and hydration,21-23 are 
necessary next steps within delirium research programs in specialist palliative care settings.    
Page 23 of 91
http://mc.http://mc.manuscriptcentral.com/palliative-medicine
Palliative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review

Limitations and strengths
A limitation of this review was that only English language studies were included. Another 
limitation was that our retrospective identification of people requiring palliative care was 
not sufficient to definitively determine outcomes for this patient sub-group; therefore this 
review makes only recommendations for future research, not clinical practice. A strength of 
this review was our systematic approach adhering to PRISMA.30  
Conclusion
This review found that studies of non-pharmacological delirium interventions have 
excluded, poorly characterised and infrequently reported outcomes for people requiring 
palliative care. Based on these findings, we suggest new approaches to generate evidence 
for delirium interventions in this important patient sub-group. First, randomised controlled 
trials of non-pharmacological interventions to prevent and treat delirium are needed in 
specialist palliative care settings, with feasibility studies required before trials of 
effectiveness. Interventions should be based on those implemented and proven effective for 
older patients, especially those who were frail and severely ill with comorbidity. Second, 
broad inclusion criteria, justified exclusions, and tailoring in future inpatient trials of non-
pharmacological delirium interventions would promote representative study populations. 
Third, systematic characterisation of the sub-groups of people requiring palliative care 
would allow their specific outcomes to be reported. Last, additional outcomes related to 
patient and family subjective experience, goals of care and quality of life would enhance the 
relevance of delirium research in inpatient settings where people are cared for at the end of 
life.  
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Inclusion, characteristics and outcomes of people 
requiring palliative care in studies of non-pharmacological 
interventions for delirium: a systematic review
Abstract
Background 
Delirium is common, distressing, serious and under-researched in specialist palliative care 
settings.
Objectives
To examine whether people requiring palliative care were included in non-pharmacological 
delirium intervention studies in inpatient settings, how they were characterised, and what 
their outcomes were.
Design 
Systematic review (PROSPERO 2017 CRD42017062178).
Data sources
Systematic search in March 2017 for non-pharmacological delirium intervention studies in 
adult inpatients. Database search terms were delirium, hospitalisation, inpatient, 
palliative care, hospice, critical care, geriatrics. Scottish Intercollegiate Guidelines 
Network methodological checklists guided risk of bias assessment.
Results 
The 29 included studies were conducted between 1994-2015 in diverse settings in 15 
countries (9136 participants, mean age 76.5 years [SD 8.1], 56% women). Most studies 
tested multicomponent interventions (n=26) to prevent delirium (n=19). Three-quarters of 
the 29 included studies (n=22) excluded various groups of people requiring palliative care; 
however, inclusion criteria, participant diagnoses, illness severity and mortality indicated 
their presence in almost all studies (n=26). Of these, 21 studies did not characterise 
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participants requiring palliative care or report their specific outcomes (72%), four reported 
outcomes for older people with frailty, dementia, cancer and comorbidities, and one was 
explicitly focused on people receiving palliative care. Study heterogeneity and limitations 
precluded definitive determination of intervention effectiveness and only allowed 
interpretations of feasibility for people requiring palliative care. Acceptability outcomes 
(intervention adverse events and patients subjective experience) were rarely reported 
overall. 
Conclusion  
Non-pharmacological delirium interventions have frequently excluded and under-
characterised people requiring palliative care and infrequently reported their outcomes. 
Key words
Clinical trial, Delirium, Hospice, Inpatient, Palliative Care, Review
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Key statements
What is already known about the topic?
 Delirium is a distressing and serious neurocognitive condition that frequently occurs for 
patients in palliative care inpatient settings.
 In contrast to other hospital settings, there is limited evidence to guide non-
pharmacological intervention to prevent and treat delirium in palliative care inpatient 
settings.
What this paper adds
 This review found that various groups of people requiring palliative care were excluded 
from three-quarters of non-pharmacological delirium intervention studies in inpatient 
settings; despite this, they were present in most studies and their outcomes were 
reported in five. 
 Non-pharmacological delirium interventions appear feasible for people requiring 
palliative care yet there is no definitive evidence they are effective or acceptable for this 
inpatient group.
Implications for research
 Phase II and III randomised controlled trials of non-pharmacological interventions to 
prevent and treat delirium are needed in specialist palliative care settings.
 Adaptations to future trials of non-pharmacological delirium interventions in other 
inpatient settings are needed to promote representative study populations and allow 
outcomes for sub-groups of people requiring palliative care to be reported. 
 Additional outcomes related to patient and family subjective experience, goals of care 
and quality of life would enhance the relevance of delirium intervention research in 
inpatient settings where people are cared for at the end of life.  
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Introduction
Delirium is a serious complication of medical illness and hospitalisation.1 The condition is 
characterised by acute disturbances to attention, awareness and cognition, has 
multifactorial aetiology, and variously affects memory, language and visuospatial ability, 
orientation and perception.2 Affected persons often experience feelings of fear, humiliation, 
confusion and disconnection from others.3, 4 Family members experience distress when 
delirium causes sudden changes in behaviour and decline in the person they love.5 6  
Patients who experience an episode of delirium during hospitalisation experience many 
poorer outcomes, including being more likely to die.1, 7, 8 
Delirium most often occurs in people with older age, advanced or severe illness and/or pre-
existing cognitive impairment. Hospital-wide, one in five patients have delirium,9 with 
occurrence higher again in intensive, geriatric and palliative care units.1, 6 Studies of delirium 
epidemiology in palliative care inpatient units that screened patients at least daily reported 
incidence of 33 45% and prevalence of 58-88% in those who died. 
Development of delirium guidelines1, 10-13 policy14 and international advocacy15 indicate 
growing awareness of the seriousness and prevalence of delirium and importance of 
evidence based care for hospitalised patients.16, 17 There now is sufficient evidence to 
implement non-pharmacological interventions for delirium in certain hospital settings.18, 19 
For example, reviews of studies of multicomponent interventions addressing physical and 
cognitive activity, sleep, hearing, vision and hydration, as in the original Hospital Elder Life 
Program (HELP) study,20 reported reduction in incident delirium in older hospitalised 
patients.21-23 Reduction in length of hospital stay and improvement in return to independent 
living were also demonstrated.22  
In contrast, guideline recommendations for non-pharmacological interventions as the first 
approach to prevent and treat delirium during advanced illness and at the end of life are not 
evidence based.10, 17, 24 A recent scoping review reported the need to generate evidence to 
inform clinical care in palliative care settings and populations, for non-pharmacological 
interventions in particular.25 Poorer outcomes with antipsychotics,26 and over-sedation 
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when benzodiazepines were given for agitated delirium,27 in two recent trials in specialist 
palliative care settings also highlight the need to establish drug-free ways to prevent and 
relieve the difficulties of delirium at the end of life. 
In response, the authors established the Studies to Understand and Improve Delirium Care 
in Palliative Settings international collaborative (SUNRISE) to generate high-quality delirium 
research in palliative care. We identified the need to inform our future trials in palliative 
care through a review of studies of non-pharmacological interventions for delirium 
conducted in a wide range of inpatient settings. This wide review was premised on our 
clinical experience and knowledge that many hospitalised patients have advanced and/or 
serious illness, frailty and high comorbidity and consequently much in common with 
patients in specialist palliative care settings, especially those in intensive care, medical and 
geriatric units where rates of delirium are similarly high. 28, 29 Based on this premise, our 
specific objectives were to examine whether people requiring palliative care were included 
in non-pharmacological delirium intervention studies in various inpatient settings, how 
these participants were characterised, and whether the non-pharmacological interventions 
were effective, feasible and/or acceptable for them. 
Methods
Design
Systematic review of the literature, following the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA).30
Participants/settings 
Adults F%* years) receiving inpatient hospital or hospice care. In this review, we refer to 
hospice as an inpatient facility with the primary function to provide specialist palliative 
care to people with life-threatening illness, and analogous to a palliative care inpatient unit. 
Search strategy
In March 2017, we searched MEDLINE, Embase, CINAHL, PsycINFO, Cochrane Library and 
Web of Science with the following search terms in MEDLINE: Delirium AND Hospitalization 
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OR Inpatient OR Hospice AND Palliative Care OR Critical Care OR Geriatrics. Filters in 
Medline were: 1. Study types: clinical study, clinical trial all, comparative study, controlled 
clinical trial, meta-analysis, multicenter study, pragmatic clinical trial, randomised controlled 
trial, systematic review; 2. Peer reviewed journal and 3. Published from 1980 onward (when 
delirium was first included in the American Psychological Association (APA) Diagnostic and 
Statistical Manual (DSM-III).31 We tailored search terms and filters to subsequent databases. 
We examined reference lists of relevant systematic reviews and meta-analyses identified in 
the search for additional eligible studies.
Inclusion/exclusion criteria
Studies included were primary reports of prospective trials (i.e. studies of an intervention 
with a comparator); with a primary objective to prevent or treat delirium through non-
pharmacological intervention/s in adult patients in hospital or hospice unit settings; a 
primary outcome of delirium incidence, severity or duration; published in English in a peer-
reviewed journal. 
Studies excluded were reports of interventions for alcohol withdrawal delirium only; 
systematic reviews and meta-analyses of non-pharmacological delirium intervention/s; 
studies where the primary outcome was not participants delirium status (e.g. process or 
cost effectiveness outcomes, validation of delirium tools); studies that did not use diagnostic 
criteria or a tool with established psychometric properties to measure delirium; protocols; 
and ongoing studies. 
Study selection, data extraction and management  
We imported search results into Endnote X7 software, removed duplicates and exported 
results to Covidence,32 where three reviewers [IAD, LE, AH] independently applied eligibility 
criteria to titles and abstracts. Reviewers compared decisions about inclusion, documented 
reasons for exclusions at full text review and resolved discrepancies through discussion. Two 
reviewers [IAD, LE] extracted data according to the template for intervention description 
and replication (TIDieR) checklist and guide 33 into an Excel V15.28 spreadsheet. The lead 
reviewer [AH] contributed guidance, oversight and independent data checking. 
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Risk of bias assessment 
Two reviewers [LE and AH] independently assessed each study for selection, performance, 
detection, attrition, confounding, and reporting biases according to the Scottish 
Intercollegiate Guidelines Network (SIGN) Methodology Checklists34 for controlled trials and 
cohort studies. Discrepancies were resolved through discussion.  
Outcomes
To identify our sample of interest (i.e. people requiring palliative care), we examined study 
inclusion and exclusion criteria, participant diagnoses (including severity or staging), and 
mortality. We assessed eligibility criteria and diagnoses against the Gold Standards 
Framework Proactive Identification Guidance (GSF PIG), a clinical tool to help identify 
people likely to need additional supportive (i.e. palliative) care in the last 12 months of life.29 
According to the GSF PIG, these people are those with life-threatening conditions, including 
illnesses that are advanced, progressive, incurable and/or likely to cause acute crises; frailty 
and co-morbidities; and sudden catastrophic events.
Previous reviews have reported effectiveness outcomes of non-pharmacological delirium 
interventions for the entire study sample; 21-23 whereas this review focused on effectiveness, 
feasibility and acceptability outcomes of our sample of interest. We examined effectiveness 
according to each studys primary outcome and any sub-group analysis for our sample of 
interest. We assessed feasibility by examining intervention characteristics, adherence and 
study modifications, and acceptability through intervention-related adverse effects and 
patient, family, clinician and volunteer subjective experiences of the interventions.
Synthesis and analysis plan
We generated tables, text and graphs to report study characteristics, participants, 
interventions and outcomes. Data transformation and descriptive numerical analyses were 
performed using Excel. We planned to perform subgroup meta-analysis using Review 
Manager Analyses software 35 of intervention effectiveness if we could definitively 
distinguish our sample of interest and if interventions and comparators and measures were 
comparable.
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Updated search
We updated the search prior to publication in February 2019 and identified two new eligible 
papers published after the original search date.36, 37 There were not incorporated as neither 
paper altered the conclusions of the review. 
Results
The original database search strategy generated 4300 records. After removing 35 duplicates 
and 4169 records through title and abstract screening, we reviewed 69 full text papers and 
excluded 48. We included another eight through reference list searching, resulting in 29 
papers reporting 29 studies for inclusion (Figure 1).
(Insert Figure 1 PRISMA Flow Diagram here)30
Study characteristics
The 29 studies were conducted between 1994-2015 across 15 countries: six in the US,38 39 40 
41 42 20 three each in Australia,43 44 45 Belgium,46-48 and Canada,49-51 two each in the 
Netherlands52, 53 and Sweden,54, 55 and one each in Chile,56 France,57 Ireland,58 Italy,59 
Japan,60 Korea,61 Singapore,62 Spain,63 UK,64 and the US/Canada65  (Table 1). 
Study designs were before/after studies (one with an additional concurrent arm62) (n=11),38-
41, 44, 45, 48, 52, 57, 62, 64 randomised controlled trials (RCTs) (n=10),42, 43, 47, 50, 51, 53, 55, 56, 61, 65 non-
randomised controlled trials (one with matched participants20) (n=5),20, 46, 54, 59, 63 a quasi-
experimental study,49 a pilot randomised controlled trial,60 and a comparative time series 
study.58 
Services and settings were medical (n=10),20, 41, 43, 50-52, 54, 56, 59, 63 geriatric (n=7),39, 44, 55, 57, 59, 
62, 63 medical and/or surgical intensive care (n=6),38, 40, 47, 58, 61, 64 perioperative hip fracture 
(n=6),42, 45, 46, 48, 55, 65 other perioperative (n=3) 52, 53, 60 and palliative care and hospice units 
(n=1), 49 with eight studies involving more than one service.47, 52, 55, 58, 59, 61, 63, 64
Most studies tested multicomponent interventions (n=26) and aimed to prevent delirium in 
non-delirious participants (n=19) (Table1). Six studies aimed to prevent and treat delirium 38, 
42, 48, 54, 55, 65 three were treatment only studies.50, 51, 62 
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(Insert Table 1 Study characteristics here) 
Code: P Prevention, T Treatment, RCT Randomised controlled trial, CTS Comparative time series, B/A Before
after study, CT Controlled trial, ICU Intensive Care Unit, NR Not reported, MC Medical Centre, M 
Multicomponent, PRCT Pilot RCT, QE Quasi-experimental, S Single component 
 Numbers signify the domains in which the study was assessed as having low risk of bias: 1 = Representative 
study sample; 2 = Concealed allocation; 3 = Random sequence generation; 4 = Blinded participants and 
intervention personnel; 5 = Blinded outcome assessors; 6 = Valid, reliable delirium measures; 7 = <20% sample 
lost to analysis; 8 = Intention to treat analysis; 9 = Confounders accounted for; 10 = Only a priori outcomes 
reported
Risk of bias assessment
Almost all studies were assessed as having at least one form of selection bias (n=28). The 
exception was a Chilean RCT of a prevention intervention where family members delivered 
cognition, vision, and hearing strategies to patients.56 Eight RCTs minimised internal 
selection bias through concealed allocation and random sequence generation.42, 43, 47, 50, 53, 55, 
56, 65 There was high risk of performance bias in all studies, due to the inherent difficulty of 
blinding non-pharmacological interventions: one RCT blinded participants to their allocation, 
43 and no studies blinded those performing the intervention. Detection bias was minimised 
in eight studies through blinded outcome assessors combined with valid, reliable delirium 
measures.42, 43, 47, 50, 51, 53-55 Although we excluded studies that did not use delirium 
diagnostic criteria and/or a tool with established psychometric properties, three studies 
were assigned uncertain risk of detection bias due to retrospective assignment of delirium 
status when the Confusion Assessment Method (CAM) was not performed during weekends 
in two before-after studies;41, 45 and when delirium incidence was reported as a mean rather 
than a proportion in a comparative time series study.58 High risk of detection bias was 
assigned to a delirium prevention study in seven Canadian palliative care units due use of a 
screening tool, the Confusion Rating Scale (CRS) to measure delirium incidence, severity and 
duration.49 Six studies had low risk of attrition bias.42, 43, 50, 55, 56, 63 Confounders were 
accounted for in 17 studies.20, 39, 40, 42, 46, 47, 49-52, 54, 55, 58, 59, 61, 63, 65 Most studies (n=22) 
reported only a priori outcomes,20, 38-43, 46, 48, 50-53, 55-57, 60-65 which we assessed by information 
provided within the papers rather than through examination of trial registrations or 
published protocols, which no studies cited.
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Figure 2 presents overall risk of bias in the included studies.
(Insert Figure 2 Overall risk of bias graph here)
Figure 2: Overall risk of bias
Participant characteristics
There were 9136 participants (n=4553 in intervention arms) across the 29 studies (Table 2). 
Sample sizes ranged from 15-1516 participants. Participants overall mean age (excluding 
two studies that reported only age range or median) 48, 58 was 76.5 years (SD + 8.1). There 
were more female participants (56%) than male. 
Inclusion and exclusion criteria 
Inclusion
Most studies (n=19) included only patients aged 65 years and older (Table 2). Twenty-two 
studies included consecutively admitted patients, 16 of which further required certain 
physical conditions to be present (e.g. frailty,53 hip fracture,42, 45, 46, 48, 55, 65 anemia,65 
dementia,57 advanced cancer,49 oesophageal cancer surgery60). Five studies included only 
patients with risk factors for delirium20, 44, 52, 56, 63 and three included only patients with 
delirium.50, 51, 62 The study in seven Canadian palliative care units (hereafter termed the 
palliative care unit study) included only patients with terminal cancer, defined as dying 
within 90 days of admission which was retrospectively identified. This study had the largest 
sample of all the studies (n=1516, 17%).49 
Exclusion
Twenty-three studies excluded patients on various diagnostic grounds (Table 2). These were 
stroke or cerebrovascular accident (CVA), moderate-severe traumatic brain injury or coma 
(n=9);20, 38, 43, 48, 50, 51, 59, 62, 63 dementia or prior cognitive impairment (n=7);20, 38, 44, 47, 61, 63, 64 
psychiatric disorders or alcohol/drug addiction (n=6);43, 44, 59-61, 64 pathological fracture 
(n=4);46, 48, 55, 65 poly- or multiple trauma (n=2);46, 48 neurologic diagnosis/neurosurgical 
(n=2);61, 64 metastatic cancer or referred to oncology services (n=2);42, 50 and others 
(myocardial infarction,65 severe renal failure,55 brain concussion,48 history of sleep 
pathology,64 severe rheumatoid arthritis 55 and severe hip osteoarthritis55). 
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Fifteen studies excluded patients with impaired verbal communication or who were 
otherwise unable to complete study assessments.20, 38, 39, 41, 43, 46, 48, 50, 52, 53, 59, 61-63, 65 Six 
studies excluded patients with hearing and/or visual impairment.46-48, 60, 61, 64 Three studies 
excluded patients isolated for infection.43, 61, 62
Eight studies explicitly excluded patients expected to die, using the following terms: 
terminal diagnosis or terminal illness (n=3),20, 58, 62 terminal condition and receiving 
comfort care (on the basis that they were unlikely to benefit from the intervention) 
(n=2),41, 44 life expectancy less than six months,46 metastatic cancer or comorbid illnesses 
likely to reduce life expectancy to less than six months,42 death expected within 24 
hours,43 and dangerously ill.62  
Two studies excluded participants who subsequently died from analysis;51, 52 a delirium 
prevention study in elderly care wards excluded 70% of 2162 admitted patients due to being 
too unwell; 39 and another study excluded patients with deterioration of condition.60 
The palliative care unit study excluded patients who lived for more than 90 days or who 
were still alive at discharge from analysis.49
Characterisation of study participants  
Participant diagnoses and illness severity
Reporting of participant diagnoses, illness severity and mortality varied. Fifteen studies 
reported co-morbid diagnoses, twelve reported only primary diagnoses, and four reported 
both (Table 2). Diagnoses categorisation varied. Studies rarely reported staging of 
diagnoses (n=2).49, 56 
Sixteen studies reported illness severity for all participants using at least one measure, more 
often as a mean or median score (n=15)20, 38, 43, 46, 47, 50, 52, 55, 56, 59, 61-65 than by categorising 
participants proportionally (n=6).20, 39, 42, 47, 52, 62 The most frequently used illness severity 
measures were the Charlson Comorbidity Index (CCI)66 (n=7; reported as: mean scores 2.3 - 
3.3,46, 50, 62 median 2,43, 56 and scores of four or greater 19.8%39 and 39%42); and the Acute 
Physiology And Chronic Health Evaluation II (APACHE II) 67 (n=6; mean scores 11.3-15.6).20, 43, 
59, 61, 63, 64 Two ICU studies that measured illness severity using the APACHE II reported 
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means scores (13.9-14.6) 61, 64 approximately equivalent to or less than those reported in 
three of four medical and geriatric unit studies (14.1-15.6).20, 43, 59 Other measures were the 
Cumulative Illness Rating ScaleGeriatrics (CIRS-G) comorbidity and severity indexes;52, 59, 68 
American Society of Anesthesiologists physical status classification (ASA)52, 65, 69; Blessed 
Dementia Rating Scale;20, 42, 70 Modified Early Warning Score (MEWS);39, 71 Sepsis-related 
Organ Failure (SOFA);47, 72 Risk, Injury, Failure, Loss of kidney function, and End-stage kidney 
disease (RIFLE);47, 73 Simplified Acute Physiology Score (SAPS 3);47, 74 and the 15-item 
Geriatric Depression Scale (GDS-15).55, 75 
Three studies reporting comorbidities without the CCI reported: i. 60% had more than two 
comorbidities (diabetes, COPD, hypertension, myocardial infarction, other cardiovascular 
disorders, neurological disorders, cerebrovascular disorders, hearing and vision problems, 
memory problems in daily life, psychiatric disorders or musculoskeletal disorders);53 ii. 72% 
had at least one co-morbid illness;47 and iii. a mean of 2.7 comorbidities.63 
Almost every diagnosis, sensory deficit and impairment that were exclusion criteria in some 
studies were reported in the overall study population (Table 2). For example, more studies 
reported participants with dementia or cognitive impairment (n=13) 39, 41-43, 46, 48-51, 55-57, 65 
than excluded people with these conditions (n=7).20, 38, 44, 47, 61, 63, 64
Participant mortality
Mortality was reported in 19 studies at nine different time points, ranging from in the 
ICU38, 40 to one year post intervention. 46, 55, 62  In these studies, 2090 participants died 
(23%). Mortality rates ranged from 1% in three studies20, 47, 61 to 100% in the palliative care 
unit study.49  There were 596 participant deaths in 18 studies reporting mortality that were 
conducted outside of a specialist palliative care setting (12%). High mortality was reported 
for intervention and control medical unit participants at eight weeks (22.1% vs 19.37%; 50 
33% vs 37% for delirious patients51) and at six months (33.8% vs 30.9%);39 and at one year 
for older (F)6+ traumatic hip fracture patients (33% vs 22%).46 Six of the 19 studies 
measuring mortality excluded patients expected to die; despite this exclusion criteria, 134 
participants of these six studies subsequently died during the study period (12%).20, 44, 46, 52, 
58, 62 Fifteen studies reported 21 comparative mortality rates,20, 38-40, 45, 46, 50-55, 61-63 only two 
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of which reported significantly less mortality in intervention cohorts compared to 
controls,54, 61 with one (at day 7 in hospital) not sustained at 30 days in hospital.61 
Study approaches to people requiring palliative care
By examination of these data we identified only one study that explicitly reported outcomes 
for participants requiring palliative care (n=1).49 Using the GSF PIG, we identified another 
four studies that reported primary or sub-group effectiveness outcomes for older people 
likely to require palliative care due to the presence of frailty, dementia, cancer and 
comorbidity.42, 52, 53, 57  All five studies were of interventions to prevent delirium. Twenty-
two studies either explicitly or resultantly excluded groups of people requiring palliative 
care (76%). 20, 38, 39, 41-44, 46-48, 50-52, 55, 58-65 Yet, through our interpretation of reported 
diagnoses, levels of comorbidity, frailty and mortality (signified with a  in Table 2), we also 
identified that people requiring palliative care were present in 21 studies that did not 
specifically characterise them or report their outcomes (72%). 20, 38-41, 43, 45-48, 50, 51, 54-56, 58, 61-
63, 65 Figure 3 presents these findings diagrammatically. 
(Insert Table 2: Study inclusion and exclusion criteria and participant diagnoses, illness 
severity and mortality)
* Statistically significant difference  Intervention and control participants combined   Rounded to nearest 
whole number  Interpreted as indicating need for palliative care 
Illness severity measures: Higher scores represent higher illness severity. AIS Abbreviated Injury Scale, 
APACHE II Acute Physiology and Chronic Health Evaluation (scores 0-71), ASA American Society of 
Anesthesiologists physical status classification (I: normal healthy patient  - VI: a declared brain-dead patient 
whose organs are being removed for donor purposes), BDRS Blessed Dementia Rating (scores 0-28, cut-off for 
impairment > 4), CCI Charlson Comorbidity Index (scores 0-37), CIRS-G Cumulative Illness Rating Scale
Geriatrics (scores 0-56), CSI Clinical severity of illness (1 (mild) - 9 (moribund)), GCS Glasgow Coma Scale 
(scores 3-15; scores 3-8 = coma), GDS-15 15-item Geriatric Depression Scale F) = suggests depression and 
need for assessment, F%% = depression/severe depression), ISS Injury Severity Score (scores 1-75), MEWS 
Modified Early Warning Score (score F6 is statistically linked to increased likelihood of death or admission to 
an intensive care unit), RIFLE (Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease 
categories), SAPS 3 Simplified acute physiology score (scores 0-217), SOFA Sepsis-related Organ Failure 
Assessment (scores 0 to 24). Other abbreviations: ADL activities of daily living, AF atrial fibrillation, Ca cancer, 
CAM Confusion Assessment Method, CAM-ICU Confusion Assessment Method for the Intensive Care Unit, CI 
cognitive impairment, CKD Chronic Kidney Disease, COPD chronic obstructive pulmonary disease, CVD 
cardiovascular disease, CVA cerebrovascular accident, DM diabetes mellitus, ED Emergency Department, GI 
gastrointestinal, HF heart failure, hrs hours, HT hypertension, I/C intervention/control, ICU intensive care unit, 
IHD ischaemic heart disease, IQR interquartile range, MI Myocardial Infarction, MMSE Mini-Mental State 
Examination, NR not reported, O/A on admission, OP osteoporosis, PVD peripheral vascular disease, RASS 
Richard Agitation Sedation Scale, RF renal failure, SD standard deviation, SICU surgical intensive care unit, TIA 
transient ischemic attack, UTI urinary tract infection.
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Figure 3: Study approaches to people requiring palliative care
NB: Combined percentages do not add up to 100% as studies simultaneously excluded and reported people requiring 
palliative care.
Effectiveness outcomes for people requiring palliative care 
Overall, 20 studies reported that the intervention was effective according to at least one 
primary outcome (69%)20, 38-42, 44-46, 51, 54-57, 59-64 
The one study explicitly focused on preventing delirium in people receiving palliative care 
(patients with terminal cancer) tested three primarily nurse-delivered intervention 
components for orientation, informing family, and assessment of medication risk factors 
plus querying physicians about changes to medication and found no statistically significant 
difference in delirium incidence (p= 0.66, OR 0.94), severity or duration between 
intervention and control sites.49 
Outcomes of four participant groups that we identified as requiring palliative care were as 
follows: 
A delirium prevention RCT of a geriatric liaison intervention of comprehensive assessment, 
cognitive and physical activity, hearing, vision and nutrition for frail elderly cancer patients 
undergoing surgery for a solid tumour reported no significant difference between delirium 
incidence in intervention and control groups (9.4% vs. 14.3%, OR: 0.63, 95% CI: 0.291.35).53
A delirium prevention RCT of geriatric consultation and multiple care components (Table 3) 
performed analysis for the sub-group pf people with dementia within a perioperative hip 
fracture population, reporting a non-statistically significant reduction in delirium incidence 
in the intervention group compared with control (n=13 (62%) vs. n=20 (69%) p=0.6).42 
A delirium prevention before-after study of orientation and communication strategies for 
patients with dementia in a French acute geriatric unit reported a 66% relative risk 
reduction of delirium in the after cohort (RRR 0.34 IC 95% 0.150.78).57
A delirium prevention before-after study of delirium/cognitive screening, comprehensive 
assessment, cognitive and physical activity, nutrition, falls prevention, medication review 
and staff education in frail elderly surgical patients found no statistically significant 
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difference in incidence of delirium (11% vs 10% p=0.945) or cognitive decline (15% vs 12% 
p=0.431) in the before group compared with the after.52  
Due to heterogeneity of study interventions and measures (Table 2), we did not conduct 
meta-analysis of these effectiveness outcomes. 
Types of outcomes measured in the included studies
Twenty-nine different outcomes were measured overall (Figure 4). There were nine 
different primary outcomes, the most frequent was delirium incidence (n=21). 20, 38, 39, 41-46, 
48, 49, 52, 53, 56-61, 63, 64 Of the 22 different secondary outcomes, the most often reported was 
length of ICU or hospital stay (n=16).38-43, 45, 46, 48, 50, 51, 53-56, 62  
Figure 4: Types and rates of outcomes measured
Feasibility outcomes
Intervention components
The interventions consisted of 24 components overall, varying in type and number per study 
(1-15) (M=6.3 SD +4) (Table 3). The type and number of strategies in each component also 
varied (data not reported here).
Eighteen multicomponent prevention interventions most often included strategies for: 
cognitive activity (n=15);20, 39, 41, 43-45, 49, 52, 53, 56, 57, 59, 61, 63, 64 physical activity (n=9);20, 39, 43, 45, 52, 
53, 59, 63, 64 hearing (n=9);20, 39, 41, 44, 45, 53, 56, 61, 63 vision (n=9);20, 39, 41, 44, 45, 53, 56, 61, 63 sleep-wake 
cycle preservation (n=8);20, 40, 41, 45, 59, 61, 63, 64 nutrition (n=8);41, 44, 45, 52, 53, 59, 61, 63 staff 
education; 39-41, 52, 59, 61, 63, 64 and hydration (n=7). 20, 41, 44, 45, 59, 61, 63 These components largely 
correspond to those of the original HELP study.20 
Components of six delirium prevention and treatment interventions were more diverse 
(M=8), with staff education (n=4),38, 48, 54, 55 staff changes (n=3) 48, 54, 55 and strategies for pain 
(n=3) most often included.42, 48, 55 
The most common components of three delirium treatment interventions were cognitive 
activity (n=3);50, 51, 62 physical activity (n=3);50, 51, 62 hearing (n=3);50, 51, 62 vision (n=3);50, 51, 62 
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sleep-wake cycle preservation (n=2);50, 62 and environmental changes (e.g. adjustments to 
lighting and noise) (n=2).51, 62 
Overall, multicomponent interventions also often included: family involvement (e.g. 
information/education about delirium, increased family presence) (n=9); 38, 45, 49-51, 56, 58, 59, 61 
environmental strategies (n=9); 38, 40, 42, 45, 50, 51, 61, 62, 64 and comprehensive assessment 
(n=8).42, 46, 50-53, 55, 61 Pharmacological strategies (e.g. medication reviews and alerts, 
protocols for pain and sedation strategies) were present in half of the multicomponent 
interventions (n=12).38, 40-42, 45, 48, 49, 52, 55, 59, 61, 64 
The three single component interventions were blood transfusion,65 bright light therapy60 
and earplugs at night.47 
The five studies that reported effectiveness outcomes for our sample of interest addressed: 
cognitive activity,42, 49, 52, 53, 57 physical activity,42, 52, 53 comprehensive assessment,42, 52, 53 
hearing,42, 53 vision,42, 53 nutrition,42, 52, 53 pharmacological strategies,42, 49, 52 environmental 
strategies42, 57 family involvement,49 staff changes,42 pain,42 medical complications,42 
oxygen,42 staff education,52 falls prevention52 delirium/cognitive screening52 and 
bladder/bowel function42 (Figure 5).
Intervention delivery
Specialist geriatric clinicians or teams led almost half of the interventions, as either 
consultants or directly (n=12).20, 39, 42, 45, 46, 50-53, 55, 62, 63 Interventions were delivered by 
interdisciplinary teams (n=5),20, 38, 45, 46, 55 physicians and nurses (n=3),49-51 nurses alone 
(n=3),47, 48, 61, physician, nurse and physiotherapists (n=2),59, 64 family members (n=2),56, 58 
and physiotherapists and allied health assistants (n=1).43 Volunteers delivered part or all of 
the intervention in four studies.20, 41, 44, 52 Three studies did not report who delivered the 
intervention, including two single component interventions. 57, 60, 65 Most studies (n=25) 
wholly or partly tailored components and strategies to patients individual needs (Table 3).
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(Insert Table 3 Intervention characteristics here)
Abbreviations: ICU Intensive Care Unit, NR Not reported, OA On admission, OT Occupational therapist, PT 
physiotherapist Component codes: C Cognitive activity, E Physical activity, H Hearing, V Vision, P Sleep-wake 
cycle preservation, W Hydration, S Staff education, F Family involvement, N Nutrition, Pa Pain, O Oxygen, L 
Falls prevention, G Staff changes, B Bladder/bowel, J Environment/lighting/noise, CA Comprehensive 
assessment, BT Blood transfusion, Z Address medical complications, PE Patient education, Ph Physiological 
monitoring, K Pharmacological
Figure 5: Types and rates of intervention components, including for sample of interest
Code: P Delirium prevention studies, P & T Combined delirium prevention and treatment studies, T Delirium treatment 
studies, S of I Sample of interest 
Adherence
Eighteen studies reported adherence to intervention strategies, using different methods and 
levels of detail (Supplementary Table 1). Almost all reported less than 100% adherence, with 
the exception reporting 100% geriatric nurse compliance with the semi-structured 
protocol.62 The palliative care unit study reported 89.7% overall adherence to the study 
protocol.49 Three studies compared adherence to intervention strategies with that for 
control participants and reported that usual care sometimes mirrored some intervention 
strategies.46, 50, 55 Two studies reported reasons for non-adherence: pharmacological 
sedation, coma and absence of a relative in the palliative care unit study; 49 and patient 
refusal or unavailability, staff member unavailability, and medical contraindications in the 
original HELP study.20
Study modifications
Two studies modified the intervention in the pilot phase, including changes in staff 
education and practice change materials,39 and providing study information to family on 
admission rather than waiting until the researcher was present. 58 The palliative care unit 
study modified the primary outcome measure by not substituting the CRS for the CAM, due 
to CAM completion delays and poor completion rates (39% of participants) caused by the 
challenge of conducting the baseline CAM structured interview in the last days or hours of 
life.49
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Acceptability outcomes
Adverse effects
No study reported systematic processes of attribution of adverse effects to the intervention. 
Ten studies reported adverse events related to hospitalisation rather than the intervention 
38, 44, 51-53, 55, 56, 62, 63 (Figure 4 and Supplementary Table 2). No study reported statistically 
significant increased adverse events for intervention participants. Two simply stated that 
the intervention had no adverse effects.20, 43 A RCT,55 a controlled trial 63 and a before-after 
study 62 reported statistically significant reductions in some adverse events for intervention 
participants: falls,55 physical restraint,62, 63 pressure ulcers,55, 62  infection,55, 62 and sleeping 
problems.55 
Patient, family, clinician and volunteer subjective experiences
No study reported patients subjective experiences of intervention (Supplementary Table 3). 
A survey of family caregivers satisfaction with intervention and care for delirious patients 
within one study found most experienced moderate to high levels of distress (72%), 
believed that the environment and intervention helped the patients recovery (86.6% and 
83.5%, respectively) and that the three most useful strategies were activity, reality 
orientation and thrice-daily mobilisation.62 A before-after study of older medical and 
surgical inpatients interviewed patients, volunteers, nurses and physicians and analysed 
meeting minutes to assess intervention integration in clinical practice, with minimal details 
of analysis methods and findings provided. 52  Four studies reported multidisciplinary and 
expert input during intervention development.39, 40, 45, 61 The RCT of nocte earplugs in the 
ICU stated in the discussion that some participants preferred not to use them in order to 
remain in direct contact with their environment. 47 No studies reported measures of 
patient distress related to delirium (Figure 5).
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Discussion
This review found that studies of non-pharmacological delirium interventions frequently 
excluded and under-characterised people requiring palliative care and subsequently their 
outcomes were infrequently reported. The likely reasons for these findings and how to 
address barriers to inclusion and report characteristics and outcomes for this patient sub-
group in future research are discussed.  
With regards to inclusion, this review identified a selection bias against people requiring 
palliative care through exclusion of people expected to die (using various prognoses and 
terminology) and also of those with greater acuity or severity of illness, particular diagnoses 
and with cognitive, sensory and/or communication impairments. These exclusions were 
rarely explained or justified and often seemingly arbitrary. Nor were they consistent across 
the studies. These exclusions represented people highly at risk of delirium.1, 6 This finding 
reflects those of other reviews that identified selection biases against people with dementia 
in geriatric research76 and older people from clinical trials in oncology.77 Reasons for the 
exclusions identified in our review are likely to be multifactorial. One factor may be 
assumptions that the interventions were not appropriate, possible or likely to be effective 
for people requiring palliative care, as indicated by the two studies which justified the 
exclusion of patients with a terminal condition and requiring comfort care as that the 
intervention would be unlikely to benefit them.41, 44 Historical views that people requiring 
palliative care are separate from the wider hospital population, rather than universally and 
always within it, may also have influenced some exclusion decisions.78, 79 There are also 
pragmatic challenges to ensuring informed consent and completion of study measures when 
patients are frail, expected to decline, and have pre-existing cognitive and sensory 
impairments. However, these challenges may be overcome through a variety of research 
strategies, such as proxy, opt out and advance consent methods, early contact, tailoring of 
interventions and messaging to patients and family, adequate research resources and 
governance, and cluster designs.26, 27, 80, 81 Outcomes such as days alive without delirium or 
coma may promote the inclusion of more severely ill patients in future delirium research, 
because consciousness is pre-requisite for delirium measurement.40, 82  Brief and 
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observational delirium diagnostic tools that can be validly used with patients with cognitive, 
sensory and communication impairment are also available.83-86
Despite most studies excluding certain groups of people likely to require palliative care, 
unsurprisingly we identified that they were indeed present, despite under-reporting of their 
characteristics and outcomes. One reason it was difficult to retrospectively distinguish this 
sub-group for the purposes of ascertaining their outcomes in this review was that the 
studies reported participants diagnoses, illness severity, and mortality using different 
measures, time-points, methods and degrees of detail. While identifying inpatients with 
palliative care needs in hospital is challenging and an uncertain science, both retrospectively 
and prospectively, there are ways it can be achieved. 29, 87-89 In addition to the GSF PIG which 
we applied in this review, 29 the Palliative Care Needs Assessment Tool 90 and the Supportive 
and Palliative Care Indicators Tool (SPICT) 91 can be used to identify which patients are at 
risk of deteriorating and dying in hospital. Other studies suggest identifying patients with 
palliative care needs through the presence of life-threatening illness coupled with receipt 
and acceptance of care focused on supporting quality of life, 87 or retrospectively though the 
use of death registration data. 89 Such methods could be used in delirium intervention 
research in settings where mortality is high, such as intensive care units, where existing 
illness severity measures focus on acuity and intensity of intervention and, despite having 
some prognostic utility, were never designed to identify a patients need for palliative 
care.67, 74, 92
Better characterisation of people requiring palliative care in studies of non-pharmacological 
interventions for delirium would help to build evidence of their outcomes in two ways. 
Firstly, it would allow sub-group analysis to be performed and reported in future studies in 
any setting. This is important because the question of whether delirium can be prevented 
and treated through non-pharmacological means was not definitively determined for this 
population by this review. The multi-site palliative care unit study had the greatest number 
of participants and reported good overall adherence to the study protocol; 49 however, the 
only core care domain 21 was cognitive activity, consisting of nurses orientating patients to 
time, person and place each shift. Planned use of the CAM was not accomplished and the 
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substituted screening tool93 was not a validated tool for delirium diagnosis or severity. All 
participants had terminal cancer and died within 90 days of admission and thereby were 
not fully representative of people requiring inpatient palliative care, including in specialist 
units49, not all of whom will die within three months. Only one geriatric unit study of people 
with dementia reported reduced delirium incidence; however, the report lacked detail, 
including of analysis methods.57 The remaining three studies were focused on frail elderly 
patients with cancer, dementia, hip fracture and comorbidity following surgery,42, 52, 53 a 
level of intervention and delirium risk that many people requiring palliative care would not 
undergo. Lastly, we found no studies focused on non-pharmacological interventions to treat 
delirium in people requiring palliative care, highlighting the particular need to research this 
challenging area of clinical care. 
Secondly, better recognition of people requiring palliative care in delirium research would 
heighten awareness of their needs, which in turn would instigate consideration of outcomes 
that are most meaningful to them. Reducing delirium incidence, duration and severity, 
length of admission and mortality were the foci of the included studies. While worthwhile 
aims at any point in the illness trajectory, more person-centred outcomes, such as reduction 
of delirium related distress, and improved patient and family caregiver experiences of 
decision making, respect and dignity, and quality of life, were almost completely absent. 5, 94 
Measuring these additional outcomes, which are highly valued by patients and family 
caregivers,95, 96 would enrich this field of research and is achievable through both 
quantitative and qualitative methods. Adverse effects of intervention will also be important 
to systematically measure in future trials, given that patients with cognitive impairment 
have increased vulnerability to harm in hospital.97 
Lastly, this review allowed an interpretation that many intervention components are 
feasible for people requiring palliative care by virtue of their delivery to elderly, frail and/or 
critically ill patients with and without delirium in the included studies. However, we suggest 
that studies measuring the feasibility of components of the original HELP intervention 20 that 
were subsequently found to be effective for other older hospitalised patients i.e. those 
targeting cognitive and physical activity, sleep, hearing, vision and hydration,21-23 are 
necessary next steps within delirium research programs in specialist palliative care settings.    
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Limitations and strengths
A limitation of this review was that only English language studies were included. Another 
limitation was that our retrospective identification of people requiring palliative care was 
not sufficient to definitively determine outcomes for this patient sub-group; therefore this 
review makes only recommendations for future research, not clinical practice. A strength of 
this review was our systematic approach adhering to PRISMA.30  
Conclusion
This review found that studies of non-pharmacological delirium interventions have 
excluded, poorly characterised and infrequently reported outcomes for people requiring 
palliative care. Based on these findings, we suggest new approaches to generate evidence 
for delirium interventions in this important patient sub-group. First, randomised controlled 
trials of non-pharmacological interventions to prevent and treat delirium are needed in 
specialist palliative care settings, with feasibility studies required before trials of 
effectiveness. Interventions should be based on those implemented and proven effective for 
older patients, especially those who were frail and severely ill with comorbidity. Second, 
broad inclusion criteria, justified exclusions, and tailoring in future inpatient trials of non-
pharmacological delirium interventions would promote representative study populations. 
Third, systematic characterisation of the sub-groups of people requiring palliative care 
would allow their specific outcomes to be reported. Last, additional outcomes related to 
patient and family subjective experience, goals of care and quality of life would enhance the 
relevance of delirium research in inpatient settings where people are cared for at the end of 
life.  
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Table 1 Study characteristics
Author, year Country Aim Design Service/setting Component Risk of bias 
Moon 2015 61 Korea P RCT 105-bed medical/surgical ICU, general 1049-bed hospital M 2,6,7,9,10
Bakker 2014 52 Netherlands P BA Frailty service, two surgical + one internal medicine department, 
university MC
M 6,7,9,10
Bryczkowski 2014 
38
US P, T BA 14-bed surgical ICU, Level I academic urban trauma centre M 6,10
Chong 2014 62 Singapore T BA + 
Control 
Geriatric Monitoring Unit for acute delirium M 6,7,10
Patel 2014 64 UK P BA 24-bed adult mixed surgical/medical ICU, teaching hospital M 6,7,10
Gruber-Baldini 
2013 65 
US & 
Canada 
P, T RCT Postoperative hip fracture services in thirteen hospitals S 2,3,6,7,9,10
Hempenius 2013 53 Netherlands P RCT Solid tumour perioperative services at university MC, large 
teaching hospital + community hospital
M 2,3,5,6,7,10
Holt 2013 39 US P BA Three specialist elderly care wards, general hospital M 6,7,9,10
Jeffs 2013 43 Australia P RCT Medical inpatients, secondary referral hospital M 2,3,4,5,6,7,8,10
Kamdar 2013 40 US P BA Medical ICU, tertiary academic hospital M 1,6,9,10
Zaubler 2013 41 US P BA 38-bed general medical floor, 600-bed teaching community 
hospital 
M 7,10
Andro, 2012 57 France P BA Acute geriatric care unit M 6,10
Deschodt 2012 46 Belgium P CT Perioperative hip fracture in two trauma wards, university 
hospital
M 6,8,9,10
Gagnon 2012 49 Canada P QE Four hospital palliative care units + three stand-alone hospices M 7,9
Martinez 2012 56 Chile P RCT Internal medicine ward in an acute hospital M 1,2,3,6,7,8,10
Van Rompaey 
2012 47
Belgium P RCT 45-bed medical/surgical/cardiac surgical ICU, 625-bed university 
hospital
S 2,3,5,6,9
Black 2011 58 Ireland P CTS Seven-bed medical and surgical ICU, inner city public hospital M 9
Bo 2009 59 Italy P CT Medical and geriatric units, university teaching hospital M 6,7,9
Vidan 2009 63 Spain P CT Geriatric and internal medicine units, large public university 
hospital
M 6,7,8,9,10
Caplan & Harper 
2007 44
Australia P BA 52 bed geriatric ward, tertiary referral university hospital M 6,7
Lundström 2007 55 Sweden P, T RCT Postoperative hip fracture service in geriatric orthopaedic + 
orthopaedic ward, university hospital 
M 2,3,5,6,7,8,9,10
Taguchi 2007 60 Japan P PRCT Postoperative oesophageal cancer service, university hospital S 3,6,10
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Author, year Country Aim Design Service/setting Component Risk of bias 
Lundström 2005 54 Sweden P, T CCT Two hospital wards, general internal medicine department M 1,5,6,9
Wong 2005 45 Australia P BA Hip-fracture service in orthopaedic ward, 460-bed metropolitan 
teaching hospital
M 1
Cole 2002 50 Canada T RCT Five medical units, 400-bed university-affiliated primary acute 
care facility
M 2,3,5,6,7,8,9,10
Marcantonio 2001 
42
US P, T RCT Perioperative hip fracture service, academic tertiary MC M 2,3,5,6,7,8,9,10
Milisen 2001 48 Belgium P, T BA Perioperative hip fracture service, emergency room + two 
trauma units, urban academic MC centre
M 6,10
Inouye 1999 20 US P CT, 
matched 
200 bed general-medicine service, 800-bed urban teaching 
hospital 
M 6,8,9,10
Cole 1994 51 Canada T RCT Medical inpatients of university-affiliated, primary acute 400-
bed hospital
M 1,5,6,8,9,10
Code: P Prevention, T Treatment, RCT Randomised controlled trial, CTS Comparative time series, B/A Beforeafter study, CT Controlled trial, ICU Intensive 
Care Unit, NR Not reported, MC Medical Centre, M Multicomponent, PRCT Pilot RCT, QE Quasi-experimental, S Single component 
 Numbers signify the domains in which the study was assessed as having low risk of bias: 1 = Representative study sample; 2 = Concealed allocation; 3 = 
Random sequence generation; 4 = Blinded participants and intervention personnel; 5 = Blinded outcome assessors; 6 = Valid, reliable delirium measures; 7 = 
<20% sample lost to analysis; 8 = Intention to treat analysis; 9 = Confounders accounted for; 10 = Only a priori outcomes reported
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Table 2 Study inclusion and exclusion criteria and participant diagnoses, illness severity and mortality 
Author, 
year
Inclusion Exclusion Sample 
size 
Age, 
Mean 
Male %   Diagnoses 
%  
Illness 
severity, 
mean or 
proportion 
Mortality 
I vs C n (%)
Moon 201561  18, ability to 
understand study 
purpose and/or 
provide consent 
independently or 
via proxy, ICU 
admission " 
hours
Persistent RASS - 4 or 
-5, severe visual and 
auditory problems 
preventing CAM-ICU, 
serious psychiatric or 
neurologic diagnosis, 
Korean MMSE score 
+,  on isolation 
ward with infection; 
death or discharge 
day admitted, 
inability for CAM-ICU 
when patient violent 
with RASS +3 or +4
134 69.7 48 Infection 25 APACHE II 
13.9
7-day in-hospital 
1 (1.7%) vs 9 
(14.3%)*
30-day in-
hospital 4 (6.7%) 
vs 11 (17.5%) 
Bakker 201452 4 admitted to 
surgical or 
medical 
departments > 48 
hrs, at risk of 
delirium, falls, 
malnutrition, 
physical decline, 
frail
Illness, language 
barriers, other 
speciality, refusal, 
logistic missing, 
delirium O/A, refusal, 
died in hospital, died 
<3 months
386 77       56  NR ASA: 
I and II 
25.5%
III and IV 
74.5%
CIRS-G 
comorbidity 
13
During 
admission 5 (3%) 
vs 3 (2%) 
Three-month 8 
(4%) vs 11 (6%) 
Bryczkowski 
201438
>50, admitted to 
SICU  24 hours
Moderate-severe 
traumatic brain injury 
(AIS score 3) , 
transfer from jail or 
in police custody, h/o 
dementia. 
Participants with 
unobtainable or 
undocumented 
123 66.5                      58        NR GCS 14.6
ISS 16.5 
(Trauma 
patients)
In-SICU 2 (3%) vs 
4 (7%) 
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Author, 
year
Inclusion Exclusion Sample 
size 
Age, 
Mean 
Male %   Diagnoses 
%  
Illness 
severity, 
mean or 
proportion 
Mortality 
I vs C n (%)
delirium status 
excluded from 
analysis
Chong 201462 > 65, admitted to 
geriatric 
medicine 
department, 
assessed to have 
delirium (either 
O/A or incident 
delirium during 
hospital stay) 
according to CAM
Medical illness 
needing special 
monitoring, 
dangerously ill 
coma, terminal 
illness, 
uncommunicative or 
severe aphasia,  
severe combative 
behaviour with high 
risk of harm, contra-
indication to bright 
light therapy, 
respiratory or 
contact precautions, 
GMU admission 
refused by family, 
patient or physician-
in-charge
320           84.3                    33 NR CCI 2.7 
Severity of 
Illness Index: 
Level 1 0.9% 
Level 2 
84.3%
Level 3 
14.8%      
During 
admission 4 
(1.7%) vs 0 
6-month 20 
(12%) 
12-month 14 
(20.5%)
(Intervention 
cohort only) 
Patel 201464 > 18,  night in 
ICU
Pre-existing sleep 
pathology, severe 
visual or hearing 
impairment, alcohol 
addiction or illicit 
drug abuse, h/o CI,  
discharge from ICU 
this admission, 
neurosurgical, 
delirium during 
study, received 
338 60.3        52         NR APACHE II 
14.6      
NR
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Author, 
year
Inclusion Exclusion Sample 
size 
Age, 
Mean 
Male %   Diagnoses 
%  
Illness 
severity, 
mean or 
proportion 
Mortality 
I vs C n (%)
sedative medications 
within 24 hrs
Gruber-Baldini 
201365
 50, surgical 
repair of hip 
fracture, 
haemoglobin <10 
g/dL <3 days 
after surgery, 
CVD or CVD risk 
factors
Unable to walk 
without human 
assistance prior to 
hip fracture, declined 
blood transfusion, 
multiple trauma,  
pathologic hip 
fracture, acute MI 
<30 days prior to 
randomisation, prior 
enrolment, 
symptoms of 
anaemia, actively 
bleeding at time of 
potential 
randomisation, non-
English speaking 
139 81.5 26 Hip fracture & 
CVD/CVD risk factors 
100 
Comorbid: Dementia 
32/AF 32/Chronic 
lung disease 21/DM 
20/ Hearing problems 
18/Visual problems 
12/Stroke/TIA 12/ Ca 
11/Alcohol abuse or 
withdrawal 
11/Parkinsons 3
ASA 2.9 NR
Hempenius 
201353
>65, undergoing 
elective surgery 
for solid tumour, 
frail according to 
>3 on Groningen 
Frailty Indicator 
at outpatient 
departments at 
participating 
centres
Unable to fill in 
questionnaire, 
unable to complete 
the study protocol 
and follow-up 
schedule before 
inclusion (e.g. 
logistical reasons or if 
extra hospital visits 
too burdensome)
297 77.5 36 >2 comorbidities 60 
(diabetes, COPD, HT, 
MI, other CVD, hearing 
and vision problems, 
memory problems, 
neurological, 
cerebrovascular, 
psychiatric or 
musculoskeletal 
disorders)/ RF 3
Surgery
Minor 25.9%
Intermediate 
21.9%
Major 52.2% 
In-hospital 7.9% 
vs 3%
(n=14 overall) 
Holt 201339 Admitted with 
acute medical 
illness from ED 
directly by GP to 
Prevalent delirium, 
too unwell to be 
assessed (in opinion 
of clinical staff), 
362 85.4              42        CI (<24 MMSE) 
58/Hearing impairment 
59 Visual impairment 
31
CCI  4 19.8
Severe 
illness (>3 
In-hospital 17 
(11.2%) vs 23 
(11.0%) 
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Author, 
year
Inclusion Exclusion Sample 
size 
Age, 
Mean 
Male %   Diagnoses 
%  
Illness 
severity, 
mean or 
proportion 
Mortality 
I vs C n (%)
participating 
geriatric wards
unable to 
communicate 
verbally in English, 
consent not obtained 
<24 hours O/A
MEWS) 0.4% 

Six-month post-
discharge 50 
(33.8%) vs 64 
(30.9%) 
Jeffs 201343  65, admitted to 
medical unit in 
the study area, in 
hospital <48 
hours
Severe dysphasia 
making 
communication 
impossible, death 
expected <24 hrs, 
infection control 
isolation, 
contraindication to 
mobilisation, 
admission to Stroke 
Unit or critical care, 
planned admission 
<48 hours, major 
psychiatric diagnosis, 
prior enrolment, 
delirium documented 
O/A, transfer from 
other hospital 
647 79.4 48  Visually impaired 23
Hearing impaired 20
Premorbid CI 14
APACHE II 
14.1
CCI median, 
IQR) 2 (13)
NR
Kamdar 
201340
 70, admitted 
from ED to 
participating 
medical ICU
None 300
 
54 52 
 
Respiratory failure 
30/GI 15/ Sepsis (non-
pulmonary) 12/CVD 
11/Other 32
NR for whole 
cohort
ICU 24 (14%) vs 
18 (16%) 
In-hospital 34 
(19%) vs 28 
(25%) 
Zaubler 
201341
4 admitted to 
general medical 
floor 
Not likely to benefit 
from the 
interventions i.e. 
non-verbal, terminal 
illness and receiving 
comfort care, refusal
595 82.7 43 CI 91/ Pneumonia 
8/UTI 7
Malaise/fatigue 6/
Cellulitis 5/Other 70
NR NR
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Author, 
year
Inclusion Exclusion Sample 
size 
Age, 
Mean 
Male %   Diagnoses 
%  
Illness 
severity, 
mean or 
proportion 
Mortality 
I vs C n (%)
Andro 201257 4	 years, 
admitted to 
acute geriatric 
unit, demented,  
not delirious 
None 255 84.8 31 Dementia 100 NR NR
Deschodt 
201246

	 verbally 
testable, 
admitted to ED 
with a traumatic 
hip fracture
No traumatology 
admission, poly-
trauma, premorbid 
assessment missed, 
life expectancy < 6 
months, refusal, 
pathological fracture, 
no surgery, non-
native speaker, no 
admission via ED, 
hard of hearing
171 80.8 27 Hip fracture 100
Dementia 21
CCI 2.3 One-year 
10 (33%) vs 13 
(22%) 
Gagnon 
201249
Admitted to 
participating 
palliative care 
units and 
hospices
Delirious on 
admission or within 
48 hours of 
admission, 
hospitalised < 48 
hours and > 90 days, 
alive at discharge
1516 68.4 
 
46 
 
Terminal cancer 100 
Comorbid: Depression 
5/Anxiety 1.3/ Bipolar 
0.5/Alzheimers 0.5/ 
Other dementias 0.8/ 
Schizophrenia or 
psychosis 0.6/ 
Alcoholism 0.5/ Drug 
dependence 0.05/ 
Personality disorders 
0.2/ Other psychiatric 
0.7
NR 90-days 1516 
(100%) (all) 
Martinez 
201256
All internal 
medicine ward 
patients at risk of 
delirium i.e. 
presence of at 
least one risk 
Delirium O/A, no 
family support, 
refused consent, 
admitted to a ward 
other than general 
internal medicine, in 
287 78.2  63  HF 29/ COPD 22/ Ca 
18/ CKD 14/Acute MI 
9/ Mild CI 8/ DM with 
end-organ damage 8/ 
Dementia 6 /PVD 
6/Previous delirium 
CCI median 
(IQR) 2 (14 

NR
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Author, 
year
Inclusion Exclusion Sample 
size 
Age, 
Mean 
Male %   Diagnoses 
%  
Illness 
severity, 
mean or 
proportion 
Mortality 
I vs C n (%)
factor:  >70, 
previous history 
of CI,  MMSE 
score <24 prior to 
admission, 
alcoholism, 
metabolic 
imbalances O/A
a room with > two 
beds
4/Mild liver disease 4/ 
Mesenchymopathies 
4/Peptic ulcer disease 
3/Metastatic Ca 3 
/Severe liver disease 2 
/Lymphoma 0.7 
/Leukaemia 0.4
Van Rompaey 
201247
  expected 
LOS in ICU >24 
hours, Dutch or 
English speaking, 
GCS score 
Hearing impairment, 
dementia, confusion 
or delirium O/A
136 59.5 66  1 Comorbidity 72  SOFA score 
first 24 hrs 
7.1
SAPS 3 2.3
Maximal 
RIFLE: 
No acute 
kidney injury 
6.3% Risk 
6.2% Injury 
17.9% 
Failure 
69.6% 
During study 
period 2 (1%) 
(overall) 
Black 201158  years, 
admitted to 
medical and 
surgical ICU, 
family member 
willing to 
participate
Terminal diagnosis 170 >60 73% NR NR NR 12-week 32 
(19%) (overall) 
Bo 200959  70 years, 
admitted from ED 
to participating 
medical and 
geriatric units
Delirium during ED 
stay or O/A, history 
of primary psychiatric 
disorder or alcohol 
abuse, coma,  
aphasia,  intubation, 
252 82.5 48     NR APACHE II 
14.3
CIRS 
comorbidity 
index 4.1
NR
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Author, 
year
Inclusion Exclusion Sample 
size 
Age, 
Mean 
Male %   Diagnoses 
%  
Illness 
severity, 
mean or 
proportion 
Mortality 
I vs C n (%)
or stroke OA,  
language barrier, 
absence of a 
caregiver
CIRS Severity 
index 0.4
Vidan 200963 4 not delirious 
O/A, at least one 
of four delirium 
risk factors (CI,  
visual 
impairment, 
acute disease 
severity,  
dehydration), 
admitted to 
participating 
geriatric and 
internal medicine 
units  
Severe dementia 
with impaired 
communication, 
aphasia, coma, 
agonic status, 
expected hospital 
stay + 48 hours
542 84 43 Comorbid: mean 2.7
Primary O/A: Visual 
impairment 60/Hearing 
impairment 
55/Infection 43/HF 21
APACHE II 
11.3
In-hospital 10 
(5.8%) vs 19 
(5.1%) 
Caplan and 
Harper 200744
4 able to 
communicate 
and enrolled O/A 
to geriatric 
wards, presence 
of at least one 
risk factor for 
delirium (MMSE 
< 24, sleep 
deprivation, ADL, 
vision or hearing 
impairment, 
immobility, 
dehydration) 
Patients who would 
not receive a benefit 
(severe dementia 
(MMSE < 10), 
psychotic disorder, 
unable to consent or 
refusal, terminal 
condition and 
receiving comfort 
care, expected 
discharge <48 hours) 
or behavioural or 
medical condition 
that may risk 
volunteers health 
and safety
37              84.7        22       Fracture 36/ Infection 
32/ Collapse 13
NR NR vs 1 (5%)
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Author, 
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severity, 
mean or 
proportion 
Mortality 
I vs C n (%)
Lundström 
200755
 4 years, 
consecutively 
admitted to 
orthopaedic 
department with 
femoral
neck fracture
<70, severe RA, 
severe hip 
osteoarthritis; severe 
RF, pathological 
fracture, bedridden 
before fracture
199 82.2 26 Comorbid: CVD 57/ OP 
52/ HT 43/ Impaired 
hearing 43/Depression 
40/Impaired vision 
39/Dementia 
32/Stroke 25/DM 
20/Wrist fracture 
20/Lung diseases 16/ 
Hip fracture 15
GDS-15 4.9 In-hospital 6 
(3%) vs 7 (7%) 
Four-month 3 
(3%) vs 6 (7%) 
12-month 7 (8%) 
vs 5 (7%) 
Taguchi 
200760 
Oesophageal Ca 
surgery, capable 
of 
communicating in 
Japanese
Mental or 
ophthalmologic 
disorders, 
reintubation, medical 
complications, 
deterioration of 
condition
15 57.5 100 Oesphageal Ca 100/ 
Diabetes 20/HT 9 
NR NR 
Lundström 
200554
 70, 
consecutively
admitted to 
participating 
medical wards
 <70, refusal to 
participate
400 80.1  44          Comorbid: DM 
33/Stroke 
25/Asthma12/ Ca 
1/Dementia 4.5
/Epilepsy 4.5 
O/A: HF 25/Infection 
18/Impaired vision 
16/Stroke 11/MI 
7/Epilepsy 6/Fever 
, 6/UTI 5/Impaired 
hearing 3
NR In-hospital 
(delirious 
patients) 
2 (3.2%) vs 9 
(14.5%)*
Wong 200545 > 50, 
osteoporotic hip 
fracture, 
admitted to 
orthopaedic ward 
during study 
period
None 99 81.8 26 Operation <24 hrs O/A 
78/Vascular disease 
41/Chronic lung 
disease 18/Diabetes 
14/Renal impairment 
11/Depression or 
anxiety 6
NR 3-month study 
period 3 (4.2%) 
vs  
Baseline 28-days 
2 (7.1%) 
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Cole 200250 
	 admitted to 
participating 
medical units 
with delirium O/A 
or < 1 week of 
admission
Primary diagnosis of 
stroke,  " hour 
stay on ICU or cardiac 
monitoring unit, 
geriatric or oncology 
service admission, 
unable to speak 
English or French, 
residence outside 
Montreal
227 82.4 46   Dementia 58 CCI 3.3
CSI 5.8   
8-week 25 
22.1%) vs 22 
(19.3%) 
Marcantonio 
200142
 65, admitted to 
the participating 
centre for 
primary surgical 
repair of hip 
fracture
Metastatic ca or 
other comorbid 
illnesses likely to 
reduce life 
expectancy <6 
months, unable to 
obtain informed 
consent <24 hours of 
surgery or 48 hours 
of admission
126 79     22 Hip fracture 100/Pre-
fracture dementia 44
" CCI 36%
" BDRS 
score 44%
NR
Milisen 200148 Admitted to ED 
with traumatic 
fracture of 
proximal femur, 
hospitalized in 
one of the two 
trauma units <24 
hours of surgery, 
Dutch-speaking, 
verbally testable
Multiple trauma,  
brain concussion, 
pathological 
fractures, surgery 
>72 hours after 
admission, aphasia, 
blindness, deafness, 
<9 years of formal 
education 
120 81
(median) 
19             Comorbid: Previous 
operations 58/Cardiac 
22/HT 18/ Vision or 
hearing problems 16/ 
DM 15/Dementia 15 
/Vascular 
15/Pulmonary 
13/Abdominal 
13/Depression 
11/Urinary 8/ 
Associated fracture 
3/Other 24
NR NR
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Author, 
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Mortality 
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Inouye 1999 20  70, admitted to 
one of three 
general-medicine 
units, no delirium 
O/A, baseline 
intermediate or 
high risk for 
delirium
Unable to participate 
in interviews 
(profound dementia 
precluding verbal 
communication, 
language barrier, 
profound aphasia,  
intubation or 
respiratory isolation), 
coma or terminal 
illness, hospital stay 
+ 48 hrs, prior 
enrolment, other 
(e.g., interviewer or 
patient unavailable)
852 79.7  39  Primary: Pneumonia 
12/Chronic lung 
disease 12/CHF 
11/IHD 8/GI 13/DM 
or metabolic disorder 
5/Ca 3/CVD 3/RF 
3/Anaemia 2/Other 32
APACHE II 
15.6 
BDRS 0.5
>2 Score 
11.5%
In-hospital 6 
(1.4%) vs 7 
(1.6%) 
Cole 1994 51 4	 delirious 
first 24 hrs OA to 
medical 
department, 
English or French 
speaking, not 
admitted to ICU 
or cardiac 
monitoring unit 
or referred to 
oncology or 
geriatric services, 
delirious
Primary diagnosis of 
CVA, not delirious 
88         86.1 54 Dementia 56  
(intervention cohort)
NR 8-week 14 (33%) 
vs 17 (37%) 
* Statistically significant difference  Intervention and control participants combined   Rounded to nearest whole number  Interpreted as indicating need for 
palliative care 
Illness severity measures: Higher scores represent higher illness severity. AIS Abbreviated Injury Scale, APACHE II Acute Physiology and Chronic Health 
Evaluation (scores 0-71), ASA American Society of Anesthesiologists physical status classification (I: normal healthy patient  - VI: a declared brain-dead patient 
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whose organs are being removed for donor purposes), BDRS Blessed Dementia Rating (scores 0-28, cut-off for impairment > 4), CCI Charlson Comorbidity Index 
(scores 0-37), CIRS-G Cumulative Illness Rating ScaleGeriatrics (scores 0-56), CSI Clinical severity of illness (1 (mild) - 9 (moribund)), GCS Glasgow Coma Scale 
(scores 3-15; scores 3-8 = coma), GDS-15 15-item Geriatric Depression Scale 6
 = suggests depression and need for assessment,  = depression/severe 
depression), ISS Injury Severity Score (scores 1-75), MEWS Modified Early Warning Score (score 	 is statistically linked to increased likelihood of death or 
admission to an intensive care unit), RIFLE (Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease categories), SAPS 3 Simplified acute 
physiology score (scores 0-217), SOFA Sepsis-related Organ Failure Assessment (scores 0 to 24). Other abbreviations: ADL activities of daily living, AF atrial 
fibrillation, Ca cancer, CAM Confusion Assessment Method, CAM-ICU Confusion Assessment Method for the Intensive Care Unit, CI cognitive impairment, CKD 
Chronic Kidney Disease, COPD chronic obstructive pulmonary disease, CVD cardiovascular disease, CVA cerebrovascular accident, DM diabetes mellitus, ED 
Emergency Department, GI gastrointestinal, HF heart failure, hrs hours, HT hypertension, I/C intervention/control, ICU intensive care unit, IHD ischaemic heart 
disease, IQR interquartile range, MI Myocardial Infarction, MMSE Mini-Mental State Examination, NR not reported, O/A on admission, OP osteoporosis, PVD 
peripheral vascular disease, RASS Richard Agitation Sedation Scale, RF renal failure, SD standard deviation, SICU surgical intensive care unit, TIA transient 
ischemic attack, UTI urinary tract infection.
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Table 3 Intervention characteristics
Author, year Care components Tailored Who delivered
Moon 2015 61 C, H, P, V, W, S, F, N, Pa, O, B, 
J, K, CA, Z
 Four researchers, ICU nurses
Bakker 2014 52 C, E, S, N, L, K, CA  Nurses, physicians, trained volunteers, with training delivered by geriatric team
Bryczkowski 2014 
38
P, S, F, D, J, K, PE  Whole team, research staff, family
Chong 2014 62 C, E, H, V, P, W, G, J NR Trained geriatric nurses, cognitive assessment by consultant geriatrician O/A
Patel 2014 64 C, E, P, S, D, Pa, J, K  Physicians, nurses, PT, senior staff acting as champions
Gruber-Baldini 
2013 65
T (blood transfusion)  NR
Hempenius 2013 53 C, E, H, V, N, CA  Consultant geriatricians and geriatric nurses
Holt 2013 39 C, E, H, V, S, Pa, B NR Specialist nurse, consultant geriatrician, nurse manager, ward staff 
Jeffs 2013 43 C, E  Allied health assistant, PT
Kamdar 2013 40 P, S, J, K  Bedside staff
Zaubler 2013 41 C, H, V, P, W, S, N, K  Elder Life Specialists, volunteers  
Andro, 2012 57 C, J NR NR
Deschodt 2012 46 G, CA  Consultative geriatrician, nurse, social worker, occupational therapist, physiotherapist, 
bedside staff 
Gagnon 2012 49 C, F, K  Bedside and research nurses, physicians 
Martinez 2012 56 C, H, V, F  Family members with education by researchers
Van Rompaey 2012 
47
P (earplugs)  Nurses
Black 2011 58 F  Nurses, family
Bo 2009 59 C, E, P, W, S, F, N, Pa, K  Physicians, nurses, PT
Vidan 2009 63 C, E, H, V, P, V, W, S, N  Geriatricians, residents, nurses (including a full-time specialist geriatric nurse)
Caplan & Harper 
2007 44 
C, H, V, W, N  Volunteers, volunteer coordinator 
Lundström 2007 55 E, P, W, S, N, Pa, O, L, G, B, K, 
CA, Z, Ph
 Nurses, PT, OT, dietician, geriatricians; liaison with orthopaedic surgeons, geriatricians 
and community colleagues for post-hospital care
Taguchi 2007 60 J (bright light)  NR
Lundström 2005 54 S, F, G  All ward staff 
Wong 2005 45 C, E, H, V, P, W, F, N, D, Pa, O, 
B, J, Z, K
 Geriatric registrar, geriatric team, nurses, nursing assistants, anaesthetist, pharmacist
Cole 2002 50 C, E, H, V, F, G, J, CA  Geriatric internist, geriatric psychiatrist, study nurse, bedside nurses 
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Author, year Care components Tailored Who delivered
Marcantonio 2001 
42
C, E, H, V, W, N, D, Pa, O, G, B, 
J, CA, Z, K
 Geriatrician consulting to orthopaedics team
Milisen 2001 48 S, Pa, G, K NR Nurses
Inouye 1999 20 C, E, H, V, P, W  A geriatric nurse, therapeutic-recreation and two Elder Life Specialists, PT, geriatrician, 
volunteers
Cole 1994 51 C, E, H, V, F, J, CA  Geriatrician, geriatric psychiatrist, liaison nurse
Abbreviations: ICU Intensive Care Unit, NR Not reported, OA On admission, OT Occupational therapist, PT physiotherapist Component codes: C Cognitive 
activity, E Physical activity, H Hearing, V Vision, P Sleep-wake cycle preservation, W Hydration, S Staff education, F Family involvement, N Nutrition, Pa Pain, O 
Oxygen, L Falls prevention, G Staff changes, B Bladder/bowel,   Environment/lighting/noise, CA Comprehensive assessment, BT Blood transfusion, Z Address 
medical complications, PE Patient education, Ph Physiological monitoring, K Pharmacological
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Figure 3 Study approaches to people r_`airing palliative care
NB: Combined percentages do not add up to 100% as studies simultaneously excluded and reported 
people requiring palliative care.
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Author, year Adherence Modifications
Moon 2015 1 NR NR
Ł 
2 [Bold: indicated and delivered by Carewell team; not bold: 
indicated and delivered by departm
 Ł Ł   Ł
ents 
for whom adherenc   ¡owe ¢Ł¡£¤    Łients for 
whom adherenc
 ¡¡¥ ¦£
 not confirme
  £ ¢Ł¡£¤§ ¨Ł¡
Ł 100%, ©Łª¡¡ ¡Ł 95%, «Ł ¢¬ 94% 
91%, Therapeutic activities 92%, Volunteers 84% 
­  ­
represents mean % of visits performed of the total which could be 
  Ł
ta from 49 patie¤® ¯Ł  discharge letter 
74% 55%, Orientation points 71% 8392%, Orientation 60%, 
Consult physiotherapist 59% 5668%, Nutrition 53%, °Ł¥
program activities 50% ±²±³® °Ł¥ Łm delirium 48% 46
±´® ©µ¶ ¦¥ ŁŁ
 42% NA, Registration food int
Ł
40% 
7483%, Medical history by proxy 32%, Consult dietitian 33% 
·³²® ¨Ł¡¡ 
22% 4648%, Discharge planning 16% 
100%, NA, Mobilizing 15%, Multidisciplinary meeting 11% NA. 
NR
Bryczkowski 
2014 3
NR NR
Chong 2014 4 100% compliance to semi-structured protocol by trained geriatric 
nurses
NR
Patel 2014 5 Overall compliance with interventions > 90%. Noise: Offer 
earplugs to all patients with RASS > 4 100%, Staff and visitors to 
speak quietly 96%, Close all doors 96%, Turn monitoring 
equipment to night mode 23:00-07:00 96%, Reduce volumes on 
all telephones 23:00-07:00 96%, No non-clinical discussions 
around patients bed spaces 92%; Light: Dim main ICU lights 
23:00-07:00 100%, Use bedside lighting for patient care 26 100%, 
Offer eye-masks to all patients with RASS > 4 25 96%; Patient 
care: Orientate patients regarding time, place and date every eight 
hours 100%, All patients requiring mechanical ventilation of the 
lungs to be assessed daily for suitability for sedation hold or trials 
of spontaneous breathing 100%, Hourly pain scores and prompt 
action to optimize analgesia 100%, Set appropriate sedation targets 
once per day (based on RASS) 100%, If patients sleep poorly or 
have a positive result on the CAM-ICU, perform a medication 
review within 24 h 96%, Complete care procedures before 23:00 
or delay completion until after 08:00 where possible 92%, Group 
care/procedures where possible 88%,  Ensure early mobilization 
when possible and appropriate 88%.
NR
Gruber-
Baldini 2013 
6
Number of units of blood transfused: None 4.5%, One unit 40.9%, 
Two units 36.4%, Three units 12.1%, E four units 6.1%. Total 
units of blood transfused post-randomization = 115 in 66 
participants.
NR
Hempenius 
2013 7
NR NR
Holt 2013 8 Staff attendance at delirium education sessions 70%, Adherence to 
delirium risk factor modification protocols 2757%. Protocol 
adherence highest for reorientation and hydration, lowest for 
mobility and constipation
During pilot phase, materials for 
education and practice change (30-min 
interactive lecture with a handout, a 
delirium quiz, a poster, reference 
material and case vignettes) were 
modified following consultation with 
local opinion leaders.
Jeffs 2013 9 Therapeutic encounters per day, median 1.4 (0.91.8), minutes of 
therapy per day median 38 (25 52) 
NR
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Kamdar 2013 
10
Checklist item completion rates 86-94%. Patient daytime 
interventions: Blinds raised 79%, Caffeine avoided after 3pm 
54%, Less than 50% of day shift spent napping 45%. Patient 
nighttime interventions: Room lights dimmed before 10pm 78%, 
Unnecessary alarms prevented 77%, Room temperature optimized 
77%, Pain appropriately controlled 68%, Room curtain closed 
before 10pm 64%, Warm bath before 10pm 49%, Television off 
59%, Medication given per sleep guideline 13%, Soft music 
offered and accepted 11%, Eye mask offered and accepted 2%, 
Earplugs offered and accepted 1%. ICU-wide nighttime 
interventions: Hallway lights dimmed by 10pm 89%, Overhead 
pages after 10pm: none 15%, 1-3 36%, >3 8%, unknown 41%. 
Estimated number of nurse interruptions between 10pm-7am: 
0-5 interruptions 28%, 6-10 interruptions 21%, >10 interruptions 
13%, NR 37%.
NR
Zaubler 2013 
11
NR NR
Andro, 2012 
12
NR NR
Deschodt 
2012 13
No significant differences between groups in care given except 
intervention participants received more occupational therapy 
(intervention 69.1%, control 41.6%, p < 0.001) and opioid pain 
medication (intervention 91.5%, control 75.3%, p=0.004) than 
controls. 2011 primary report: Recommendations made for 79 of 
94 participants in intervention group (84.0%). No 
recommendations given to 15 participants because no need for 
additional advice on top of usual care could be identified. Of 338 
recommendations for 79 participants, adherence could not be 
determined for nine recommendations, leaving 329 
recommendations for study (97.3%). The occupational therapist 
made nine recommendations with unknown adherence, suggesting 
walking aids or adapted footgear. Mean number of 
recommendations per participant was 4.3+/- 2.1 (range 1-10). 
Complete adherence: 56.8%, partial adherence 10.6%. Trauma 
ward team did not comply with 32.5% of recommendations.
NR
Gagnon 2012 
14
CRS score assigned: 91.2%. Adherence to CAM: 39%. Overall 
adherence to study protocols: 89.7%. Pharmacological risk alert: 
91.2%, Orientation protocol: 84.5%, Family intervention: 84.1%. 
Most common reasons for noncompliance with study protocols 
were pharmacological sedation and coma. Main reason for missed 
family intervention was absence of a relative.
CAM was not used as an outcome 
measure as per study protocol as it was 
obtained in only 39% of patients (due 
to challenges conducting the baseline 
CAM structured interview in the last 
days or hours of life). Delays in 
completion also rendered results 
invalid.
Martinez 
2012 15
NR NR
Van Rompaey 
2012 16
"No accidental or intentional removal of the earplugs was 
reported."
NR
Black 2011 17 NR During pilot phase, there was a change 
to the study protocol allowing the 
study information and booklet to be 
given to families on admission rather 
than wait until the researcher was 
present, following feedback from two 
families.
Bo 2009 18 NR NR
Vidan 2009 19 Overall rate of adherence (percentage of actions per days 
performed in each of the seven targeted intervention domains): 
75.7% of patient-days per intervention actions. Highest was 
mobilization: 91%, lowest was sleep preservation: 50%.
NR
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Caplan & 
Harper 2007 
20
NR NR
Lundström 
2007 21
27 eligible patients excluded due to failed inclusion routines. More 
documented assessment of underlying causes of delirium in the 
intervention ward compared with the control ward (2.28±1.25 
vs 0.90±0.90, p <0.001), also more documented treatments for 
underlying causes of delirium (1.69±1.56 vs 0.56±0.98, p <0.001). 
Delirious control patients more often given sedatives (41.7% 
vs 15.4%, p =0.008) and opioid drugs on demand (61.7% 
vs 30.8%, p =0.004) than intervention participants.
NR
Taguchi 2007 
22
Bright light therapy started at 3.1+/-1.4 days after surgery and 
performed over a mean of 2.8+/-0.9 days for 110+/-14 min each 
day
NR
Lundström 
2005 23
NR NR
Wong 2005 24 Daily CAM ratings 97.2%. Geriatric registrar recommendation 
(average six/patient) 89.9%. Recommendations: Regulation of 
bladder and bowel function 24%, Early detection/treatment of 
major complications 22%, Correction of fluid and electrolyte 
imbalance 14.4%, Discontinuation of unnecessary medications 
13.8%, Provision of adequate oxygen delivery 8.5%, Treatment of 
severe pain 5.4%, Treatment of agitated delirium 4.3%, Use of 
appropriate environmental stimuli 3.4%, Adequate nutritional 
intake 2.4%, Early mobilization and rehabilitation 1.8%
NR
Cole 2002 25 97% patients received the intervention (mean of 1.4 days after 
enrolment) as planned. Consultants had a mean of 1.96 contacts 
(median 1.0, range 16) with each patient in the intervention group 
and made a mean of 6.02 recommendations (median 1.0, range 1
17) per patient, most frequently for medication changes or 
investigations. Recommendations: Medication changes 73.2%, 
investigations 69%, other recommendations (e.g., patient supports, 
mobilization) 20.6%. Study nurse contact with each patient: mean 
of 11.7 (SD 9.8) (median 8.0, range 139), lasting a mean of 35.7 
(SD 28.8) minutes (median 30, range 5240). Mean total time 
spent with each patient was 418 (SD 282) minutes (median 318, 
range 901315). Four most frequent study nurse activities were 
assessment and support of patients, and education and support of 
nursing staff and families. I vs C comparisons: Geriatric or 
geriatric psychiatry consultation 100% v.18%, Study nurse visit 
100% v. 0%, Documentation of delirium by attending physicians 
41% v. 27%, p = 0.03, Decreases in medication 66.4% v. 57.9%, p 
= 0.19, Occupational therapy, recreational therapy or social work 
consultation 64.6% v. 54.4%, p = 0.12, Emotional support by ward 
nurses 14.3% v. 9.4%, p = 0.70, Orienting cues by ward nurses 
23.2% v. 16.7%, p = 0.22, Personal possessions at the bedside 
35.4% v. 22.8%, p = 0.04.
NR
Marcantonio 
2001 26
Initial geriatrics consultation preoperatively 61%, remainder had 
initial consultation within 24 hours of surgery. 591 
recommendations/mean of 9.5 recommendations per patient (range 
321). Overall adherence rate by orthopedics team: 77%. Data did 
not describe overall management; therefore, comparable data were 
not available for the usual-care group. Consultants did not 
recommend things that the orthopedists or nurses were already 
doing; only when something was not being done that they felt 
should be. Recommended/adhered: Adequate CNS oxygen 
delivery: Supplemental oxygen to keep saturation >90%, 
preferably >95% 29%/ 89%, Treatment to raise systolic blood 
pressure >2/3 baseline or >90 mmHg 4 6%/100%, Transfusion to 
keep hematocrit >30% 92%/79%, Fluid/electrolyte balance: 
Treatment to restore serum sodium, potassium, glucose to normal 
limits (glucose <300 mg/dl, <16.5 mmol/L for diabetics) 37%/96% 
NR
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Treat fluid overload or dehydration detected by examination or 
blood tests 48%/90% Treatment of severe pain: Around-the-
clock acetaminophen (1 gram four times daily) 40%/32% Early-
stage break-through pain: low-dose subcutaneous morphine, avoid 
meperidine 21%/62%, Late-stage break-through pain: oxycodone 
as needed 5%/67%, Elimination of unnecessary medications: 
Discontinue/minimize benzodiazepines, anticholinergics, 
antihistamines 68%/83%, Eliminate drug interactions, adverse 
effects, modify drugs accordingly 21%/54%, Eliminate medication 
redundancies 13%63% Regulation of bowel/bladder function: 
Bowel movement by postoperative day 2 and every 48 hours 
68%57%, D/c urinary catheter by postoperative day 2, screen for 
retention or incontinence 71%/89%, Skin care program for patients 
with established incontinence 3%/100% Adequate nutritional 
intake: Dentures used properly, proper positioning for meals, 
assist as needed 56%/66%, Supplements: 1 can Ensure,* 3 cans 
Ensure* for poor oral intake 35%/45%, If unable to take food 
orally, feed via temporary nasogastric tube 2%/100% Early 
mobilization and rehabilitation: Out of bed on postoperative day 
1 and several hours daily 58%/81% Mobilize/ambulate by nursing 
staff as tolerated, such as to bathroom 29%/72%, Daily physical 
therapy; occupational therapy if needed 2%/100% Prevention, 
early detection, and treatment of major postoperative 
complications: Myocardial infarction/ischemia
electrocardiogram, cardiac enzymes if needed 34%/81% 
Supraventricular arrhythmias/atrial  fibrillationappropriate rate 
control, electrolyte adjustments, anticoagulation 5%/3 100%, 
Pneumonia/chronic obstructive pulmonary disease - screening, 
treatment, including chest therapy 44%/67%, Pulmonary embolus 
-appropriate anticoagulation 50%/100%, Screening for and 
treatment of urinary tract infection 52%/63% Appropriate 
environmental stimuli: Appropriate use of glasses and hearing 
aids 5%/67%, Provision of clock and calendar 0%, If available, 
use of radio, tape recorder, and soft lighting 0% Treatment of 
agitated delirium: Appropriate diagnostic workup/management 
2%/100%, For agitation, calm reassurance, family presence, and/or 
sitter 3%/100%, For agitation, if absolutely necessary, low-dose 
haloperidol 0.250.5 mg every 4 hours as needed; if 
contraindicated, use lorazepam at same dose 19%/83%.
Milisen 2001 
27
NR NR
Inouye 1999 
28
Overall rate of adherence (complete and partial adherence, based 
on patient days) to all intervention protocols: 87%. Orientation 
protocol 96%, vision protocol 92%, hearing protocol 92%, 
therapeutic activities 86%, early mobilization 84%, volume 
repletion 81%, non-pharmacological sleep protocol 71%. Most 
common reasons for non-adherence included refusal by the 
patient, lack of availability of patient because of procedures 
elsewhere in the hospital, medical contraindications, and lack of 
availability of intervention staff members. 
NR
Cole 1994 29 Initial recommendations made for all 39 patients in the 
intervention group who were assessed on admission, with 25 
follow-up recommendations. Initial recommendations: 
Investigations (n=4), drug prescriptions (n=3), other (n=7) or a 
combination (n=25). Follow-up recommendations: investigations 
(n=1), drug prescriptions (n=1), other (n=3) or a combination 
(n=20). Number of nurse follow-up notes 0-8 (mean 3); 97% of 
eligible notes completed. Rates of full compliance with initial 
recommendations ranged from: Other 96% - investigations 
77%. Rates for follow-up recommendations ranged from: Other 
91% - investigations 50%.
NR
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Author, year Adverse events
Moon 2015 1 Mortality  see Table 3 
Bakker 2014 2  Complication 45% v. 40%
Bryczkowski 2014 3 Restraint-free days/30 mean 27 (95% CI 26, 29) v. mean 28 (95% CI 27, 29)
Chong 2014 4 º»¼½¾¿¼ ÀÁ ÂÃÄ¼¿À¼ÃÄÅ¾Ã ÀÁ Æ¾ÃÄ¿¾ÇÈ ÉÊËÌÅÍÎl restraint use: 44.7% v. 0 v. 23.1*, Chemical restraint 
use: 72.3% v. 40.3% v. 33.3%, Falls: 2.1% v. 1.3% v. 2.6%, Urinary catheter use: 31.9% v. 29.1% v. 
25.6, Pressure ulcer rate: 9.1% v. 4.1% v. 1.3%*, Nosocomial infection: 23.4% v. 10.7% v. 7.7%*
Patel 2014 5 NR
Gruber-Baldini 2013 6 Infections 4.6% vs 4.2%, PE 3.0% vs 0, CHF 1.5% vs 2.8%, Hemorrhaging (>100cc) 9.1% vs 5.6% 
Hempenius 2013 7 Postoperative complications: Pulmonary 24.4% vs 20.3%, Neurological 6.3% vs 6.0%, 
Cardiovascular 31.5% vs 27.8%, Thromboembolic 0.8% vs 0, Bleeding 8.7% vs 4.5%, Wound 
infection 10.2% vs 9.0%, Wound dehiscence 3.1% vs 3.0%, UTI 6.3% vs 5.3%, Anastomotic 
leakage 3.9% vsn1.5%, Pressure ulcer 3.9% vs 5.3%, RF 3.9% vs 1.5%, Electrolyte disturbance 
11.8% vs 9.0%, Fall 3.1% vs 1.5%, Urinary retention 11.8% vs 9.0%, Ileus/gastroparesis 7.1% vs 
10.5%
Holt 2013 8 Mortality  see Table 3  
Jeffs 2013 9 "No adverse events were reported."
Kamdar 2013 10 Mortality  see Table 3 
Zaubler 2013 11 NR
Andro, 2012 12 NR
Deschodt 2012 13 Mortality  see Table 3
Gagnon 2012 14 NR
Martinez 2012 15 Falls 0 v. 2.8%
Van Rompaey 2012 16 NR
Black 2011 17 NR
Bo 2009 18 NR
Vidan 2009 19 Results reported graphically, no exact figures. Physical restraints approximately 2% v. 10%*, Falls 
approximately 2% v. 1%
Caplan & Harper 
2007 20
Falls 6.3% vs 19%, Increased unplanned readmissions at 1 month 31.3% vs 19%
ÏÐÃÑÌÄ¿ÒÓ ÔÕÕÖ
21 Anemia 86.3% vs 82.3%, Constipation 37.3% vs 48.5%, Decubitus ulcers 8.8% vs 22.1%*, 
Depression 49.5% vs 54.6%, Diarrhea 21.6% vs 27.1%, HF 5.9% vs 11.6%, Pneumonia 4.9% vs 
3.1%, UTI 31.4% vs 51.0%* Other infections, 17.8% vs 17.7%, Sleeping problems 27.5% vs 
45.4%*, MI 2% vs 4.1%, Nutritional complications 24.5% v. 38.1%, PE 2% vs 0, Stroke 0 vs 1%, 
Stomach ulcers 3%) vs 4.1%, Urinary retention 15.7% vs 18.6%, Falls 11.8% vs 26.8%*
Taguchi 2007 22 NR
Lundström 2005 23 Mortality  see Table 3  
Wong 2005 24 NR
Cole 2002 25 Mortality  see Table 3
Marcantonio 2001 26 NR
Milisen 2001 27 Mortality  see Table 3  
Inouye 1999 28 "No adverse effects were associated with the intervention protocols."
Cole 1994 29 Restraint use 37% v. 29%
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Structured summary 2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility 
criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions 
and implications of key findings; systematic review registration number. 
1-2
INTRODUCTION 
Rationale 3 Describe the rationale for the review in the context of what is already known. 4-5
Objectives 4 Provide an explicit statement of questions being addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS). 
5
METHODS 
Protocol and registration 5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide 
registration information including registration number. 
1 
(registration)
Eligibility criteria 6 Specify study characteristics (e.g., PICOS, length of follow×up) and report characteristics (e.g., years considered, 
language, publication status) used as criteria for eligibility, giving rationale. 
6
Information sources 7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched. 
6
Search 8 Present full electronic search strategy for at least one database, including any limits used, such that it could be 
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6
Study selection 9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, 
included in the meta
×
analysis). 
6
Data collection process 10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any 
processes for obtaining and confirming data from investigators. 
6
Data items 11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and 
simplifications made. 
6-7
Risk of bias in individual 
studies 
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was 
done at the study or outcome level), and how this information is to be used in any data synthesis. 
7
Summary measures 13 State the principal summary measures (e.g., risk ratio, difference in means). NA
Synthesis of results 14 Describe the methods of handling data and combining results of studies, if done, including measures of 
consistency (e.g., I2) for each meta×analysis. 
7
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8, Figure 
1
Study characteristics 18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and 
provide the citations. 
8, Table 
1
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intervention group (b) effect estimates and confidence intervals, ideally with a forest plot. 
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Risk of bias across studies 22 Present results of any assessment of risk of bias across studies (see Item 15). 9, Figure 
2
Additional analysis 23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]). NA
DISCUSSION 
Summary of evidence 24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to 
key groups (e.g., healthcare providers, users, and policy makers). 
18-21
Limitations 25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of 
identified research, reporting bias). 
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Conclusions 26 Provide a general interpretation of the results in the context of other evidence, and implications for future research. 22
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